300 results on '"Pham, Hang"'
Search Results
252. Measurement of the prompt $D^0$ nuclear modification factor in $p$Pb collisions at $\sqrt{s_\mathrm{NN}} = 8.16$ TeV
- Author
-
Aaij, Roel, Abdelmotteleb, Ahmed Sameh Wagih, Abellan Beteta, Carlos, Abudinén, Fernando Jesus, Ackernley, Thomas, Adeva, Bernardo, Adinolfi, Marco, Afsharnia, Hossein, Agapopoulou, Christina, Aidala, Christine Angela, Aiola, Salvatore, Ajaltouni, Ziad, Akar, Simon, Akiba, Kazuyoshi, Albrecht, Johannes, Alessio, Federico, Alexander, Michael, Alfonso Albero, Alejandro, Aliouche, Zakariya, Alvarez Cartelle, Paula, Amato, Sandra, Amey, Jake Lewis, Amhis, Yasmine, An, Liupan, Anderlini, Lucio, Andersson, Martin, Andreianov, Aleksei, Andreotti, Mirco, Andreou, Dimitra, Ao, Dong, Archilli, Flavio, Artamonov, Alexander, Artuso, Marina, Aslanides, Elie, Atzeni, Michele, Audurier, Benjamin, Bachmann, Sebastian, Bachmayer, Marie, Back, John, Bailly-Reyre, Aurelien, Baladron Rodriguez, Pablo, Balagura, Vladislav, Baldini, Wander, Baptista de Souza Leite, Juan, Barbetti, Matteo, Barlow, Roger, Barsuk, Sergey, Barter, William, Bartolini, Matteo, Baryshnikov, Fedor, Basels, Jan-Marc, Bassi, Giovanni, Batsukh, Baasansuren, Battig, Alexander, Bay, Aurelio, Beck, Anja, Becker, Maik, Bedeschi, Franco, Bediaga, Ignacio, Beiter, Andrew, Belavin, Vladislav, Belin, Samuel, Bellee, Violaine, Belous, Konstantin, Belov, Ilia, Belyaev, Ivan, Bencivenni, Giovanni, Ben-Haim, Eli, Berezhnoy, Alexander, Bernet, Roland, Berninghoff, Daniel, Bernstein, Harris Conan, Bertella, Claudia, Bertolin, Alessandro, Betancourt, Christopher, Betti, Federico, Bezshyiko, Iaroslava, Bhasin, Srishti, Bhom, Jihyun, Bian, Lingzhu, Bieker, Martin Stefan, Biesuz, Nicolo Vladi, Bifani, Simone, Billoir, Pierre, Biolchini, Alice, Birch, Matthew, Bishop, Fionn Caitlin Ros, Bitadze, Alexander, Bizzeti, Andrea, Blago, Michele Piero, Blake, Thomas, Blanc, Frederic, Blusk, Steven, Bobulska, Dana, Boelhauve, Julian Alexander, Boente Garcia, Oscar, Boettcher, Thomas, Boldyrev, Alexey, Bondar, Nikolay, Borghi, Silvia, Borsato, Martino, Borsuk, Jozef Tomasz, Bouchiba, Sonia Amina, Bowcock, Themistocles, Boyer, Alexandre, Bozzi, Concezio, Bradley, Matthew John, Braun, Svende, Brea Rodriguez, Alexandre, Brodzicka, Jolanta, Brossa Gonzalo, Arnau, Brundu, Davide, Buonaura, Annarita, Buonincontri, Laura, Burke, Aodhan Tomas, Burr, Christopher, Bursche, Albert, Butkevich, Anatoly, Butter, Jordy Sebastiaan, Buytaert, Jan, Byczynski, Wiktor, Cadeddu, Sandro, Cai, Hao, Calabrese, Roberto, Calefice, Lukas, Cali, Stefano, Calladine, Ryan, Calvi, Marta, Calvo Gomez, Miriam, Camargo Magalhaes, Patricia, Campana, Pierluigi, Campora Perez, Daniel Hugo, Campoverde Quezada, Angel Fernando, Capelli, Simone, Capriotti, Lorenzo, Carbone, Angelo, Carboni, Giovanni, Cardinale, Roberta, Cardini, Alessandro, Carli, Ina, Carniti, Paolo, Carus, Leon David, Casais Vidal, Adrian, Caspary, Rowina, Casse, Gianluigi, Cattaneo, Marco, Cavallero, Giovanni, Cavallini, Viola, Celani, Sara, Cerasoli, Jacopo, Cervenkov, Daniel, Chadwick, Abbie Jane, Chapman, Matthew George, Charles, Matthew, Charpentier, Philippe, Chavez Barajas, Carlos Alberto, Chefdeville, Maximilien, Chen, Chen, Chen, Shanzhen, Chernov, Aleksei, Chernyshenko, Serhii, Chobanova, Veronika, Cholak, Serhii, Chrzaszcz, Marcin, Chubykin, Aleksei, Chulikov, Vladimir, Ciambrone, Paolo, Cicala, Maria Flavia, Cid Vidal, Xabier, Ciezarek, Gregory, Ciullo, Giuseppe, Clarke, Peter, Clemencic, Marco, Cliff, Harry, Closier, Joel, Cobbledick, John Leslie, Coco, Victor, Coelho, Joao A.B, Cogan, Julien, Cogneras, Eric, Cojocariu, Lucian, Collins, Paula, Colombo, Tommaso, Congedo, Liliana, Contu, Andrea, Cooke, Naomi, Coombs, George, Corredoira, Imanol, Corti, Gloria, Couturier, Benjamin, Craik, Daniel Charles, Crkovská, Jana, Cruz Torres, Melissa Maria, Currie, Robert, da Silva, Cesar Luiz, Dadabaev, Shakhzod, Dai, Lingyun, Dall'Occo, Elena, Dalseno, Jeremy, d'Ambrosio, Carmelo, Danilina, Anna, d'Argent, Philippe, Davies, Jonathan Edward, Davis, Adam, de Aguiar Francisco, Oscar, de Boer, Jan, de Bruyn, Kristof, de Capua, Stefano, de Cian, Michel, de Freitas Carneiro da Graca, Ulisses, de Lucia, Erika, de Miranda, Jussara, de Paula, Leandro, de Serio, Marilisa, de Simone, Dario, de Simone, Patrizia, de Vellis, Fabio, de Vries, Jacco, Dean, Cameron Thomas, Debernardis, Francesco, Decamp, Daniel, Dedu, Vlad-George, del Buono, Luigi, Delaney, Blaise, Dembinski, Hans Peter, Denysenko, Vadym, Deschamps, Olivier, Dettori, Francesco, Dey, Biplab, Di Cicco, Alessandro, Di Nezza, Pasquale, Didenko, Sergey, Dieste Maronas, Lorena, Ding, Shuchong, Dobishuk, Vasyl, Dolmatov, Aleksandr, Dong, Chenzhi, Donohoe, Amanda May, Dordei, Francesca, dos Reis, Alberto, Douglas, Lauren, Downes, Anthony Gavin, Dudek, Maciej Wojciech, Dufour, Laurent, Duk, Viacheslav, Durante, Paolo, Durham, John Matthew, Dutta, Deepanwita, Dziurda, Agnieszka, Dzyuba, Alexey, Easo, Sajan, Egede, Ulrik, Egorychev, Victor, Eidelman, Semen, Eisenhardt, Stephan, Ek-In, Surapat, Eklund, Lars, Ely, Scott, Ene, Alexandru, Epple, Eliane, Escher, Stephan, Eschle, Jonas Nathanael, Esen, Sevda, Evans, Timothy, Falcao, Lucas, Fan, Yanting, Fang, Bo, Farry, Stephen, Fazzini, Davide, Feo, Mauricio, Fernez, Alex Daniel, Ferrari, Fabio, Ferreira Lopes, Lino, Ferreira Rodrigues, Fernando, Ferreres Sole, Silvia, Ferrillo, Martina, Ferro-Luzzi, Massimiliano, Filippov, Sergey, Fini, Rosa Anna, Fiorini, Massimiliano, Firlej, Miroslaw, Fischer, Kamil Leszek, Fitzgerald, Dillon Scott, Fitzpatrick, Conor, Fiutowski, Tomasz, Fleuret, Frederic, Fontana, Marianna, Fontanelli, Flavio, Forty, Roger, Foulds-Holt, Daniel, Franco Lima, Vinicius, Franco Sevilla, Manuel, Frank, Markus, Franzoso, Edoardo, Frau, Giulia, Frei, Christoph, Friday, David Anthony, Fu, Jinlin, Fuehring, Quentin, Gabriel, Emmy, Galati, Giuliana, Gallas Torreira, Abraham, Galli, Domenico, Gambetta, Silvia, Gan, Yuyue, Gandelman, Miriam, Gandini, Paolo, Gao, Yuanning, Garau, Michela, Garcia Martin, Luis Miguel, Garcia Moreno, Paula, García Pardiñas, Julián, Garcia Plana, Beatriz, Garcia Rosales, Felipe Andres, Garrido, Lluis, Gaspar, Clara, Geertsema, Robbert Erik, Gerick, David, Gerken, Louis Lenard, Gersabeck, Evelina, Gersabeck, Marco, Gershon, Timothy, Giambastiani, Luca, Gibson, Valerie, Giemza, Henryk Karol, Gilman, Alexander Leon, Giovannetti, Matteo, Gioventù, Alessandra, Gironella Gironell, Pere, Giugliano, Carmen, Giza, Maciej Artur, Gizdov, Konstantin, Gkougkousis, Evangelos Leonidas, Gligorov, Vladimir, Göbel, Carla, Golobardes, Elisabet, Golubkov, Dmitry, Golutvin, Andrey, Gomes, Alvaro, Gomez Fernandez, Sergio, Goncalves Abrantes, Fernanda, Goncerz, Mateusz, Gong, Guanghua, Gorelov, Igor Vladimirovich, Gotti, Claudio, Grabowski, Jascha Peter, Grammatico, Thomas, Granado Cardoso, Luis Alberto, Graugés, Eugeni, Graverini, Elena, Graziani, Giacomo, Grecu, Alexandru Tudor, Greeven, Lex Marinus, Grieser, Nathan Allen, Grillo, Lucia, Gromov, Sergey, Gruberg Cazon, Barak Raimond, Gu, Chenxi, Guarise, Marco, Guittiere, Manuel, Günther, Paul Andre, Gushchin, Evgeny, Guth, Andreas, Guz, Yury, Gys, Thierry, Hadavizadeh, Thomas, Haefeli, Guido, Haen, Christophe, Haimberger, Jakob, Haines, Susan, Halewood-Leagas, Tabitha, Halvorsen, Marius Maehlum, Hamilton, Phoebe Meredith, Hammerich, Jan, Han, Qundong, Han, Xiaoxue, Hansen, Eva Brottmann, Hansmann-Menzemer, Stephanie, Hao, Lei, Harnew, Neville, Harrison, Thomas, Hasse, Christoph, Hatch, Mark, He, Jibo, Heijhoff, Kevin, Heinicke, Kevin, Henderson, Riley Dylan Leslie, Hennequin, Arthur Marius, Hennessy, Karol, Henry, Louis, Heuel, Johannes, Hicheur, Adlène, Hill, Donal, Hilton, Martha, Hollitt, Sophie, Hou, Ruiwen, Hou, Yingrui, Hu, Jiangqiao, Hu, Jifeng, Hu, Wenhua, Hu, Xiaofan, Huang, Wenqian, Huang, Xiaotao, Hulsbergen, Wouter, Hunter, Ross John, Hushchyn, Mikhail, Hutchcroft, David, Ibis, Philipp, Idzik, Marek, Ilin, Dmitrii, Ilten, Philip, Inglessi, Alexander, Iniukhin, Aleksandr, Ishteev, Artur, Ivshin, Kuzma, Jacobsson, Richard, Jage, Hendrik, Jaimes Elles, Sergio Javier, Jakobsen, Sune, Jans, Eddy, Jashal, Brij Kishor, Jawahery, Abolhassan, Jevtic, Vukan, Jiang, Xiaojie, John, Malcolm, Johnson, Daniel, Jones, Christopher, Jones, Thomas Peter, Jost, Beat, Jurik, Nathan, Juszczak, Izabela, Kandybei, Sergii, Kang, Youen, Karacson, Matthias, Karpenkov, Dmitrii, Karpov, Maksim, Kautz, Jacob William, Keizer, Floris, Keller, Dustin Michael, Kenzie, Matthew, Ketel, Tjeerd, Khanji, Basem, Kharisova, Anastasiia, Kholodenko, Sergei, Kirn, Thomas, Kirsebom, Veronica Soelund, Kitouni, Ouail, Klaver, Suzanne, Kleijne, Nico, Klimaszewski, Konrad, Kmiec, Mateusz Rafal, Koliiev, Serhii, Kondybayeva, Almagul, Konoplyannikov, Anatoly, Kopciewicz, Pawel, Kopecna, Renata, Koppenburg, Patrick, Korolev, Mikhail, Kostiuk, Igor, Kot, Oleksander, Kotriakhova, Sofia, Kozachuk, Anastasiia, Kravchenko, Polina, Kravchuk, Leonid, Krawczyk, Rafal Dominik, Kreps, Michal, Kretzschmar, Sophie Katharina, Krokovny, Pavel, Krupa, Wojciech, Krzemien, Wojciech, Kubat, Jakub, Kucewicz, Wojciech, Kucharczyk, Marcin, Kudryavtsev, Vasily, Kunde, Gerd Joachim, Lacarrere, Daniel, Lafferty, George, Lai, Adriano, Lampis, Andrea, Lancierini, Davide, Lane, John Jake, Lane, Richard, Lanfranchi, Gaia, Langenbruch, Christoph, Langer, Jan, Lantwin, Oliver, Latham, Thomas, Lazzari, Federico, Lazzaroni, Massimo, Le Gac, Renaud, Lee, Sook Hyun, Lefèvre, Regis, Leflat, Alexander, Legotin, Sergey, Lenisa, Paolo, Leroy, Olivier, Lesiak, Tadeusz, Leverington, Blake, Li, Hengne, Li, Kechen, Li, Peilian, Li, Shiyang, Li, Yiming, Li, Zhuoming, Liang, Xixin, Lin, Chuangxin, Lin, Tai-Hua, Lindner, Rolf, Lisovskyi, Vitalii, Litvinov, Roman, Liu, Guoming, Liu, Huanhuan, Liu, Qian, Liu, Shuaiyi, Lobo Salvia, Aniol, Loi, Angelo, Lollini, Riccardo, Lomba Castro, Julian, Longstaff, Iain, Lopes, Jose, López Soliño, Saúl, Lovell, George Holger, Lu, Yu, Lucarelli, Chiara, Lucchesi, Donatella, Luchuk, Stanislav, Lucio Martinez, Miriam, Lukashenko, Valeriia, Luo, Yiheng, Lupato, Anna, Luppi, Eleonora, Lusiani, Alberto, Lynch, Kate, Lyu, Xiao-Rui, Ma, Lishuang, Ma, Ruiting, Maccolini, Serena, Machefert, Frederic, Maciuc, Florin, Macko, Vladimir, Mackowiak, Patrick, Maddrell-Mander, Samuel, Madhan Mohan, Lakshan Ram, Maevskiy, Artem, Maisuzenko, Dmitrii, Majewski, Maciej Witold, Malczewski, Jakub Jacek, Malde, Sneha, Malecki, Bartosz, Malinin, Alexander, Maltsev, Timofei, Malygina, Hanna, Manca, Giulia, Mancinelli, Giampiero, Manuzzi, Daniele, Manzari, Claudio Andrea, Marangotto, Daniele, Marchand, Jean François, Marconi, Umberto, Mariani, Saverio, Marin Benito, Carla, Marinangeli, Matthieu, Marks, Jörg, Marshall, Alexander Mclean, Marshall, Phillip John, Martelli, Gabriele, Martellotti, Giuseppe, Martinazzoli, Loris, Martinelli, Maurizio, Martinez Santos, Diego, Martinez Vidal, Fernando, Massafferri, André, Materok, Marcel, Matev, Rosen, Mathad, Abhijit, Matiunin, Viacheslav, Matteuzzi, Clara, Mattioli, Kara Renee, Mauri, Andrea, Maurice, Emilie, Mauricio, Joan, Mazurek, Michal, Mccann, Michael, Mcconnell, Lucas, Mcgrath, Tamaki Holly, Mchugh, Niall Thomas, Mcnab, Andrew, Mcnulty, Ronan, Mead, James Vincent, Meadows, Brian, Meier, Gerwin, Melnychuk, Dmytro, Meloni, Simone, Merk, Marcel, Merli, Andrea, Meyer Garcia, Lucas, Mikhasenko, Mikhail, Milanes, Diego Alejandro, Millard, Edward James, Milovanovic, Marko, Minard, Marie-Noelle, Minotti, Alessandro, Mitchell, Sara Elizabeth, Mitreska, Biljana, Mitzel, Dominik Stefan, Mödden, Antje, Mohammed, Rizwaan Adeeb, Moise, Razvan-Daniel, Mokhnenko, Sergei, Mombächer, Titus, Monroy, Igancio Alberto, Monteil, Stephane, Morandin, Mauro, Morello, Gianfranco, Morello, Michael Joseph, Moron, Jakub, Morris, Adam Benjamin, Morris, Andrew George, Mountain, Raymond, Mu, Hongjie, Muheim, Franz, Mulder, Mick, Müller, Katharina, Murphy, Colm Harold, Murray, Donal, Murta, Rebecca, Muzzetto, Piera, Naik, Paras, Nakada, Tatsuya, Nandakumar, Raja, Nanut, Tara, Nasteva, Irina, Needham, Matthew, Neri, Nicola, Neubert, Sebastian, Neufeld, Niko, Neustroev, Petr, Newcombe, Ryan, Niel, Elisabeth Maria, Nieswand, Simon, Nikitin, Nikolay, Nolte, Niklas Stefan, Normand, Camille, Nunez, Cynthia, Oblakowska-Mucha, Agnieszka, Obraztsov, Vladimir, Oeser, Thomas, O'Hanlon, Daniel Patrick, Okamura, Shinichi, Oldeman, Rudolf, Oliva, Federica, Olivares, Mario Edgardo, Onderwater, Gerco, O'Neil, Ryunosuke Hugo, Otalora Goicochea, Juan Martin, Ovsiannikova, Tatiana, Owen, Patrick, Oyanguren, Maria Aranzazu, Ozcelik, Ozlem, Padeken, Klaas Ole, Pagare, Bhagyashree, Pais, Preema Rennee, Pajero, Tommaso, Palano, Antimo, Palutan, Matteo, Pan, Yue, Panshin, Gennady, Papanestis, Antonios, Pappagallo, Marco, Pappalardo, Luciano, Pappenheimer, Cheryl, Parker, William, Parkes, Christopher, Passalacqua, Barbara, Passaleva, Giovanni, Pastore, Alessandra, Patel, Mitesh, Patrignani, Claudia, Pawley, Christopher James, Pearce, Alex, Pellegrino, Antonio, Pepe Altarelli, Monica, Perazzini, Stefano, Pereima, Dmitrii, Pereiro Castro, Asier, Perret, Pascal, Petric, Marko, Petridis, Konstantinos, Petrolini, Alessandro, Petrov, Aleksandr, Petrucci, Stefano, Petruzzo, Marco, Pham, Hang, Philippov, Anton, Piandani, Roberto, Pica, Lorenzo, Piccini, Mauro, Pietrzyk, Boleslaw, Pietrzyk, Guillaume, Pili, Martina, Pinci, Davide, Pisani, Flavio, Pizzichemi, Marco, Placinta, Vlad-Mihai, Plews, Jonathan, Plo Casasus, Maximo, Polci, Francesco, Poli Lener, Marco, Poliakova, Mariia, Poluektov, Anton, Polukhina, Natalia, Polyakov, Ivan, Polycarpo, Erica, Ponce, Sebastien, Popov, Dmitry, Popov, Sergei, Poslavskii, Stanislav, Prasanth, Kodassery, Promberger, Laura, Prouve, Claire, Pugatch, Valery, Puill, Veronique, Punzi, Giovanni, Qi, Hongrong, Qian, Wenbin, Qin, Ning, Qu, Sanqiang, Quagliani, Renato, Raab, Naomi Veronika, Rabadan Trejo, Raul Iraq, Rachwal, Bartlomiej, Rademacker, Jonas, Rajagopalan, Rohan, Rama, Matteo, Ramos Pernas, Miguel, Rangel, Murilo, Ratnikov, Fedor, Raven, Gerhard, Rebollo de Miguel, Miguel, Redi, Federico, Reiss, Florian, Remon Alepuz, Clara, Ren, Zan, Renaudin, Victor, Resmi, P.K, Ribatti, Roberto, Ricci, Alessandro Maria, Ricciardi, Stefania, Rinnert, Kurt, Robbe, Patrick, Robertson, Gary, Rodrigues, Ana Barbara, Rodrigues, Eduardo, Rodriguez Lopez, Jairo Alexis, Rodriguez Rodriguez, Efren, Rollings, Alexandra Paige, Roloff, Philipp, Romanovskiy, Vladimir, Romero Lamas, Marcos, Romero Vidal, Antonio, Roth, Jordan Daniel, Rotondo, Marcello, Rudolph, Matthew Scott, Ruf, Thomas, Ruiz Fernandez, Ramon Angel, Ruiz Vidal, Joan, Ryzhikov, Artem, Ryzka, Jakub, Saborido Silva, Juan Jose, Sagidova, Naylya, Sahoo, Niladribihari, Saitta, Biagio, Salomoni, Matteo, Sanchez Gras, Cristina, Sanderswood, Izaac, Santacesaria, Roberta, Santamarina Rios, Cibran, Santimaria, Marco, Santovetti, Emanuele, Saranin, Danila, Sarpis, Gediminas, Sarpis, Mindaugas, Sarti, Alessio, Satriano, Celestina, Satta, Alessia, Saur, Miroslav, Savrina, Darya, Sazak, Halime, Scantlebury Smead, Luke George, Scarabotto, Alessandro, Schael, Stefan, Scherl, Sigrid, Schiller, Manuel, Schindler, Heinrich, Schmelling, Michael, Schmidt, Burkhard, Schmitt, Sebastian, Schneider, Olivier, Schopper, Andreas, Schubiger, Maxime, Schulte, Sebastian, Schune, Marie Helene, Schwemmer, Rainer, Sciascia, Barbara, Sciuccati, Augusto, Sellam, Sara, Semennikov, Alexander, Senghi Soares, Mara, Sergi, Antonino, Serra, Nicola, Sestini, Lorenzo, Seuthe, Alex, Shang, Yiduo, Shangase, Desmond Mzamo, Shapkin, Mikhail, Shchemerov, Ivan, Shchutska, Lesya, Shears, Tara, Shekhtman, Lev, Shen, Zhihong, Sheng, Shuqi, Shevchenko, Vladimir, Shields, Edward Brendan, Shimizu, Yuya, Shmanin, Evgenii, Shupperd, Joseph David, Siddi, Benedetto Gianluca, Silva Coutinho, Rafael, Simi, Gabriele, Simone, Saverio, Singla, Minni, Skidmore, Nicola, Skuza, Raphael, Skwarnicki, Tomasz, Slater, Mark, Slazyk, Igor, Smallwood, Jennifer Clare, Smeaton, John Gordon, Smith, Eluned, Smith, Mark, Snoch, Aleksandra, Soares Lavra, Lais, Sokoloff, Michael, Soler, Paul, Solomin, Anatoly, Solovev, Aleksandr, Solovyev, Ivan, Souza de Almeida, Felipe Luan, Souza de Paula, Bruno, Spaan, Bernhard, Spadaro Norella, Elisabetta, Spiridenkov, Eduard, Spradlin, Patrick, Sriskaran, Viros, Stagni, Federico, Stahl, Marian, Stahl, Sascha, Stanislaus, Seophine, Steinkamp, Olaf, Stenyakin, Oleg, Stevens, Holger, Stone, Sheldon, Strekalina, Daria, Suljik, Fidan, Sun, Jiayin, Sun, Liang, Sun, Yipeng, Svihra, Peter, Swallow, Paul Nathaniel, Swientek, Krzysztof, Szabelski, Adam, Szumlak, Tomasz, Szymanski, Maciej Pawel, Taneja, Shantam, Tanner, Alastair Roger, Tat, Martin Duy, Terentev, Aleksandr, Teubert, Frederic, Thomas, Eric, Thompson, Daniel James David, Thomson, Kayleigh Anne, Tilquin, Hanae, Tisserand, Vincent, t'Jampens, Stephane, Tobin, Mark, Tomassetti, Luca, Tonani, Giorgia, Tong, Xingyu, Torres Machado, Diego, Tou, da Yu, Trifonova, Ekaterina, Trilov, Stoyan Miroslavov, Trippl, Carina, Tuci, Giulia, Tully, Alison, Tuning, Niels, Ukleja, Artur, Unverzagt, Daniel Joachim, Ursov, Eduard, Usachov, Andrii, Ustyuzhanin, Andrey, Uwer, Ulrich, Vagner, Alexander, Vagnoni, Vincenzo, Valassi, Andrea, Valenti, Giovanni, Valls Canudas, Nuria, van Beuzekom, Martinus, van Dijk, Maarten, van Hecke, Hubert, van Herwijnen, Eric, van Veghel, Maarten, Vazquez Gomez, Ricardo, Vazquez Regueiro, Pablo, Vázquez Sierra, Carlos, Vecchi, Stefania, Velthuis, Jaap, Veltri, Michele, Venkateswaran, Aravindhan, Veronesi, Michele, Vesterinen, Mika, Vieira, Daniel, Vieites Diaz, Maria, Vilasis-Cardona, Xavier, Vilella Figueras, Eva, Villa, Andrea, Vincent, Pascal, Volle, Felicia Carolin, Vom Bruch, Dorothea, Vorobyev, Alexey, Vorobyev, Vitaly, Voropaev, Nikolai, Vos, Kimberley, Waldi, Roland, Walsh, John, Wang, Chishuai, Wang, Jialu, Wang, Jianchun, Wang, Jianqiao, Wang, Jike, Wang, Mengzhen, Wang, Rui, Wang, Yilong, Wang, Zhenzi, Wang, Zirui, Wang, Ziyi, Ward, Jake Alexander, Watson, Nigel, Websdale, David, Weisser, Constantin, Westhenry, Benedict Donald C, White, Dylan Jaide, Whitehead, Mark, Wiederhold, Aidan Richard, Wiedner, Dirk, Wilkinson, Guy, Wilkinson, Michael K, Williams, Ifan, Williams, Mike, Williams, Mark Richard James, Williams, Richard Morgan, Wilson, Fergus, Wislicki, Wojciech, Witek, Mariusz, Witola, Lukas, Wong, Cheuk Ping, Wormser, Guy, Wotton, Stephen, Wu, Hangyi, Wyllie, Kenneth, Xiang, Zhiyu, Xiao, Dong, Xie, Yuehong, Xu, Ao, Xu, Jingyi, Xu, Li, Xu, Menglin, Xu, Qingnian, Xu, Zehua, Xu, Zhihao, Yang, Di, Yang, Shuangli, Yang, Youhua, Yang, Zhenwei, Yang, Zishuo, Yeomans, Lauren Emma, Yin, Hang, Yu, Jiesheng, Yuan, Xuhao, Zaffaroni, Ettore, Zavertyaev, Mikhail, Zdybal, Milosz, Zenaiev, Oleksandr, Zeng, Ming, Zhang, Dongliang, Zhang, Liming, Zhang, Shulei, Zhang, Shunan, Zhang, Yanxi, Zhang, Yu, Zharkova, Alina, Zhelezov, Alexey, Zheng, Yangheng, Zhou, Tianwen, Zhou, Xiaokang, Zhou, Yixiong, Zhovkovska, Valeriia, Zhu, Xianglei, Zhu, Xiaoyu, Zhu, Zhanwen, Zhukov, Valery, Zou, Quan, Zucchelli, Stefano, Zuliani, Davide, Zunica, Gianluca, Laboratoire de Physique de Clermont (LPC), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA), Laboratoire de Physique Nucléaire et de Hautes Énergies (LPNHE (UMR_7585)), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique des 2 Infinis Irène Joliot-Curie (IJCLab), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Centre de Physique des Particules de Marseille (CPPM), Aix Marseille Université (AMU)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Laboratoire Leprince-Ringuet (LLR), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Annecy de Physique des Particules (LAPP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), and LHCb
- Subjects
hep-ex ,Nuclear Theory ,parton: distribution function ,FOS: Physical sciences ,suppression ,transverse momentum ,[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex] ,nucl-ex ,8160 GeV-cms/nucleon ,D0: direct production ,LHC-B ,High Energy Physics - Experiment ,High Energy Physics - Experiment (hep-ex) ,rapidity ,kinematics ,[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex] ,Nuclear Physics - Experiment ,High Energy Physics::Experiment ,Nuclear Experiment (nucl-ex) ,Nuclear Experiment ,p nucleus: scattering ,Particle Physics - Experiment ,experimental results - Abstract
The production of prompt $D^0$ mesons in proton-lead collisions in the forward and backward configurations at a center-of-mass energy per nucleon pair of $\sqrt{s_\mathrm{NN}} = 8.16~\mathrm{TeV}$ is measured by the LHCb experiment. The nuclear modification factor of prompt $D^0$ mesons is determined as a function of the transverse momentum $p_\mathrm{T}$, and rapidity in the nucleon-nucleon center-of-mass frame $y^*$. In the forward rapidity region, significantly suppressed production with respect to $pp$ collisions is measured, which provides significant constraints of nuclear parton distributions and hadron production down to the very low Bjorken-$x$ region of $\sim 10^{-5}$. In the backward rapidity region, a suppression with a significance of 2.0 - 3.8 standard deviations compared to nPDF expectations is found in the kinematic region of $p_\mathrm{T}>6~\mathrm{GeV}/c$ and $-3.25, Comment: All figures and tables, along with any supplementary material and additional information, are available at https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-007.html (LHCb public pages)
253. 上肢運動制御における筋シナジーの抽出と実装
- Author
-
ファム, ハン スィ スゥ, Pham, Hang Thi Thu, ファム, ハン スィ スゥ, and Pham, Hang Thi Thu
254. 上肢運動制御における筋シナジーの抽出と実装
- Author
-
ファム, ハン スィ スゥ, Pham, Hang Thi Thu, ファム, ハン スィ スゥ, and Pham, Hang Thi Thu
255. Molecular mechanisms underlying phenotypic degeneration in Cordyceps militaris: insights from transcriptome reanalysis and osmotic stress studies.
- Author
-
Hoang, Chinh Q., Duong, Giang H. T., Tran, Mai H., Vu, Tao X., Tran, Tram B., and Pham, Hang T. N.
- Subjects
- *
CORDYCEPS , *OSMOTIC pressure , *PHENOTYPES , *TRANSCRIPTOMES , *FRUITING bodies (Fungi) , *RADIAL stresses - Abstract
Phenotypic degeneration in Cordyceps militaris poses a significant concern for producers, yet the mechanisms underlying this phenomenon remain elusive. To address this concern, we isolated two strains that differ in their abilities to form fruiting bodies. Our observations revealed that the degenerated strain lost the capacity to develop fruiting bodies, exhibited limited radial expansion, increased spore density, and elevated intracellular glycerol levels. Transcriptome reanalysis uncovered dysregulation of genes involved in the MAPK signaling pathway in the degenerate strain. Our RT-qPCR results demonstrated reduced expression of sexual development genes, along with upregulation of genes involved in asexual sporulation, glycerol synthesis, and MAPK regulation, when compared to the wild-type strain. Additionally, we discovered that osmotic stress reduced radial growth but increased conidia sporulation and glycerol accumulation in all strains. Furthermore, hyperosmotic stress inhibited fruiting body formation in all neutralized strains. These findings indicate dysregulation of the MAPK signaling pathway, the possibility of the activation of the high-osmolarity glycerol and spore formation modules, as well as the downregulation of the pheromone response and filamentous growth cascades in the degenerate strain. Overall, our study sheds light on the mechanisms underlying Cordyceps militaris degeneration and identifies potential targets for improving cultivation practices. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
256. Anti-neuroinflammatory effects of alkaloid-enriched extract from Huperzia serrata on lipopolysaccharide-stimulated BV-2 microglial cells.
- Author
-
Dang, Thu Kim, Hong, Seong-Min, Dao, Vui Thi, Tran, Phuong Thi Thu, Tran, Hiep Tuan, Do, Giang Hoang, Hai, Thanh Nguyen, Nguyet Pham, Hang Thi, and Kim, Sun Yeou
- Subjects
- *
MITOGENS , *MITOGEN-activated protein kinases , *NITRIC-oxide synthases , *TUMOR necrosis factors , *MICROGLIA , *ENZYME-linked immunosorbent assay , *ALKALOIDS - Abstract
Alkaloid-enriched extract of Huperzia serrata (Thunb.) Trevis (Lycopodiaceae) (HsAE) can potentially be used to manage neuronal disorders. This study determines the anti-neuroinflammatory effects of HsAE on lipopolysaccharide (LPS)-stimulated BV-2 microglial cells and the underlying mechanisms. BV-2 cells were pre- or post-treated with different concentrations of HsAE (25-150 µg/mL) for 30 min before or after LPS induction. Cell viability was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and no cytotoxicity was found. Nitric oxide (NO) concentration was determined using Griess reagent. The levels of prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were determined using enzyme-linked immunosorbent assay. The levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 and the phosphorylation of mitogen-activated protein kinase (MAPK) were analyzed using western blotting. HsAE reduced LPS-induced NO production with half-maximal inhibitory concentration values of 99.79 and 92.40 µg/mL at pre- and post-treatment, respectively. Pre-treatment with HsAE at concentrations of 50, 100, and 150 µg/mL completely inhibited the secretion of PGE2, TNF-α, IL-6, and IL-1β compared to post-treatment with HsAE. This suggests that prophylactic treatment is better than post-inflammation treatment. HsAE decreased the expression levels of iNOS and COX-2 and attenuated the secretion of pro-inflammatory factors by downregulating the phosphorylation of p38 and extracellular signal-regulated protein kinase in the MAPK signaling pathway. HsAE exerts anti-neuroinflammatory effects on LPS-stimulated BV-2 cells, suggesting that it may be a potential candidate for the treatment of neuroinflammation in neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
257. One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
- Author
-
Coney, Joseph M, McCoy, Jasmyne E, Sinha, Samriddhi Buxy, Sonbolian, Nina, Zhou, Lujia, Hull, Thomas P, Lewis, Shawn A, Miller, David G, Novak, Michael A, Pendergast, Scott D, Pham, Hang, Platt, Sean M, Rao, Llewelyn J, Schartman, Jerome P, Singerman, Lawrence J, Donkor, Richard, Fink, Margaret, Zubricky, Ryan, and Karcher, Helene
- Subjects
- *
MACULAR degeneration , *ENDOTHELIAL growth factors , *VASCULAR endothelial growth factor antagonists , *VISUAL acuity - Abstract
Retrospective, real-world study to evaluate visual acuity (VA), anti-vascular endothelial growth factor (anti-VEGF) injection intervals, and central macular thickness (CMT) in neovascular age-related macular degeneration (nAMD) eyes switched to brolucizumab only or to brolucizumab alternating with another anti-VEGF.Methods: The overall study population comprised eyes that were given ≥ 1 brolucizumab injection between 1 October 2019 and 30 November 2021. The brolucizumab-only (BRO) cohort consisted of prior anti-VEGF-treated eyes treated exclusively with ≥ 3 brolucizumab injections over ≥ 12 or ≥ 18 months; the alternating brolucizumab (ALT) cohort comprised prior anti-VEGF-treated eyes treated with ≥ 2 brolucizumab injections and ≥ 1 other anti-VEGF over ≥ 12 or ≥ 18 months.Results: A total of 482 eyes received ≥ 1 brolucizumab injection during the study period. Mean VA changes from baseline were − 1.1± 15.1 letters (BRO cohort; n = 174) and 1.3± 13.0 letters (ALT cohort; n = 47) at Month 12, and 0.0± 13.5 letters (BRO cohort; n = 95) and − 7.3± 17.2 letters (ALT cohort; n = 29) at Month 18. Mean changes in injection intervals were +26.9± 48.1 days (BRO cohort) and +11.1± 17.3 days (ALT cohort) at Month 12 and +36.3± 52.3 days (BRO cohort) and +14.0± 19.9 days (ALT cohort) at Month 18. Mean changes in CMT were − 35.2± 108.1 μm (BRO cohort) and − 31.5± 91.2 μm (ALT cohort) at Month 12 and − 38.9± 75.0 μm (BRO cohort) and − 9.0± 59.9 μm (ALT cohort) at Month 18. Intraocular inflammation-related adverse events were recorded in 22/482 (4.6%) eyes.Conclusion: Treatment with either brolucizumab alone or brolucizumab alternating with another anti-VEGF can preserve vision, reduce CMT, and extend anti-VEGF injection intervals in patients with nAMD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
258. Effects of Roasting Conditions on Antibacterial Properties of Vietnamese Turmeric (Curcuma longa) Rhizomes.
- Author
-
Nguyen, Hai Thanh, Wu, Siyuan, Ootawa, Tomoki, Nguyen, Hieu Chi, Tran, Hong Thi, Pothinuch, Pitchaya, Pham, Hang Thi Thu, Do, Anh Thi Hong, Hoang, Hao Thanh, Islam, Md. Zahorul, Miyamoto, Atsushi, and Nguyen, Ha Thi Thanh
- Subjects
- *
TURMERIC , *HEAT treatment , *ROASTING (Cooking) , *BACTERIAL diseases , *MANUFACTURING processes , *CURCUMIN - Abstract
Processing with heat treatment has been reported to alter several therapeutic effects of turmeric. In Vietnamese traditional medicine, turmeric has been long used for bacterial infections, and roasting techniques are sometimes applied with this material. However, there have been no studies investigating the effects of these thermal processes on the plant's antibacterial properties. Our study was therefore performed to examine the changes that roasting produced on this material. Slices of dried turmeric were further subjected to light-roasting (80 °C in 20 min) or dark-roasting (160 °C in 20 min) processes. Broth dilution and agar-well diffusion methods were applied to examine and compare the effects of ethanol extracts obtained from non-roasted, light-roasted and dark-roasted samples, on a set of 6 gram-positive and gram-negative bacteria. In both investigations, dark-roasted turmeric was significantly less antibacterial than non-roasted and light-roasted materials, as evident by the higher values of minimum inhibitory concentrations and the smaller diameters of induced inhibitory zones. In addition, dark-roasting was also found to clearly reduce curcumin contents, total polyphenol values and antioxidant activities of the extracts. These results suggest that non-roasting or light-roasting might be more suitable for the processing of turmeric materials that are aimed to be applied for bacterial infections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
259. The impact of credit ratings and CEOs' work experience on earnings management and post-issue performance of U.S. IPOs
- Author
-
Pham, Hang Minh
- Subjects
- 658.15, HG4551 Stock exchanges
- Abstract
The IPO market is characterised by a high level of information asymmetry; thus, self-interested managers have strong incentives to overstate earnings during the IPO to inflate stock prices. Prior literature has provided evidence of earnings manipulation by managers around IPOs. If managers opportunitically manipulate earnings in the IPO year, the reported earnings will not be sustainable, and the IPO firms will exhibit negative abnormal stock returns in subsequent periods due to investors' downward adjustment of their evaluation of the firm value. Another common phenomenon of the IPO markets is the underperformance of IPO firms in the post-issue periods, with nearly a third of issuers either failing or being acquired within five years of going public. Therefore, in this thesis, I aim to examine potential factors contributing to restraining the level of earnings management undertaken by IPO firms and improving the post-issue long-term performance. Specifically, I investigate the impact of credit ratings and CEOs' work experience on earnings management and post-issue performance of newly listed firms. I uncover strong evidence that newly listed firms going public with a credit rating are less likely to engage in income-enhancing earnings management through both accruals and real operating activities manipulation. Moreover, while unrated IPO firms manipulate earnings to mislead investors, rated issuers tend to employ accounting discretion for informative purposes. I also study the association between CEOs' financial experience and earnings management around IPOs and find that IPO firms with financial expert CEOs are less likely to manage earnings through accruals. Furthermore, financial expert CEOs tend to be informative in financial reporting to allow investors to properly gauge the fair value of the firm. In addition, I investigate the influence of CEOs' specialist managerial experience on the probability of failure and survivability of IPO firms. My findings suggest that specialist CEOs enhance the ability of IPO firms to remain viable for a longer period of time. My research not only contributes to a wide range of literature on IPOs, credit ratings, earnings management and managerial attributes but also provides several practical implications for regulators in monitoring IPO firms' financial reporting, for investors in making investment decisions, and for firms in considering relevant work experience for CEO appointment.
- Published
- 2016
260. Anti-MRSA-acting carbamidocyclophanes H−L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.
- Author
-
Preisitsch, Michael, Harmrolfs, Kirsten, Pham, Hang TL, Heiden, Stefan E, Füssel, Anna, Wiesner, Christoph, Pretsch, Alexander, Swiatecka-Hagenbruch, Monika, Niedermeyer, Timo HJ, Müller, Rolf, and Mundt, Sabine
- Published
- 2015
- Full Text
- View/download PDF
261. Anti-hypertensive effects of Callisia fragrans extract on Reno-vascular hypertensive rats.
- Author
-
Le, Xoan Thi, Thi Nguyen, Loan Thanh, Nguyen, Phuong Thi, Nguyen, Tai Van, Nguyen, Hiep Van, Nguyet Pham, Hang Thi, Tran, Hong Nguyen, Hoang, Thang Dac, Van Le, Dong, and Matsumoto, Kinzo
- Subjects
- *
DIASTOLIC blood pressure , *SYSTOLIC blood pressure , *HYPERTENSION , *ANGIOTENSIN converting enzyme , *BLOOD pressure - Abstract
This study aims to investigate the anti-hypertensive effects of aqueous extract of Callisia fragrans and their underlying mechanism using a two-kidney one-clip (2K1C) model of reno-vascular hypertension in rats. The reno-vascular hypertensive rats were treated with C. fragrans leaf extract (100 and 500 mg/kg; p.o.) and a reference drug, captopril (20 mg/kg; p.o.), for 4 weeks. The blood pressure and heart rate were recorded using a tail-cuff. The heart weight, left ventricular wall thickness, and serum creatinine and urea levels were measured. A spectrophotometric assay was used to analyze the angiotensin-converting enzyme (ACE) inhibition activity of the extract and the reference drug. The total volume and the concentration of sodium, potassium, and chloride in urine samples were evaluated. C. fragrans extract significantly reduced both systolic and diastolic blood pressures in the reno-vascular hypertensive rats. No significant difference in the heart rate was observed between each animal group. C. fragrans extract reduced the 2K1C-induced increase in the heart and body weight ratio and the left ventricular wall thickness. Moreover, the extract also attenuated the increase in serum urea induced by the 2K1C treatment. C. fragrans extract inhibited ACE activity in vitro with an IC50 of 20.97 ± 3.94 µg/ml. The urine output and urinary electrolyte excretion significantly increased in C. fragrans extract-treated rats. These findings demonstrated that C. fragrans extract can mitigate hypertension and alleviate ventricular hypertrophy and renal dysfunction in reno-vascular hypertensive rats, at least in part via ACE activity inhibition and diuretic property. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
262. 3-oxo-C12:2-HSL, quorum sensing molecule from human intestinal microbiota, inhibits pro-inflammatory pathways in immune cells via bitter taste receptors.
- Author
-
Coquant, Garance, Aguanno, Doriane, Brot, Loïc, Belloir, Christine, Delugeard, Julie, Roger, Nathalie, Pham, Hang-Phuong, Briand, Loïc, Moreau, Marielle, de Sordi, Luisa, Carrière, Véronique, Grill, Jean-Pierre, Thenet, Sophie, and Seksik, Philippe
- Abstract
In the gut ecosystem, microorganisms regulate group behaviour and interplay with the host via a molecular system called quorum sensing (QS). The QS molecule 3-oxo-C12:2-HSL, first identified in human gut microbiota, exerts anti-inflammatory effects and could play a role in inflammatory bowel diseases where dysbiosis has been described. Our aim was to identify which signalling pathways are involved in this effect. We observed that 3-oxo-C12:2-HSL decreases expression of pro-inflammatory cytokines such as Interleukine-1β (− 35%) and Tumor Necrosis Factor-α (TNFα) (− 40%) by stimulated immune RAW264.7 cells and decreased TNF secretion by stimulated PBMC in a dose-dependent manner, between 25 to 100 µM. Transcriptomic analysis of RAW264.7 cells exposed to 3-oxo-C12:2-HSL, in a pro-inflammatory context, highlighted JAK-STAT, NF-κB and TFN signalling pathways and we confirmed that 3-oxo-C12:2-HSL inhibited JAK1 and STAT1 phosphorylation. We also showed through a screening assay that 3-oxo-C12:2-HSL interacted with several human bitter taste receptors. Its anti-inflammatory effect involved TAS2R38 as shown by pharmacologic inhibition and led to an increase in intracellular calcium levels. We thus unravelled the involvement of several cellular pathways in the anti-inflammatory effects exerted by the QS molecule 3-oxo-C12:2-HSL. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
263. Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression.
- Author
-
Le, Xoan Thi, Nguyen, Hien Thu, Nguyen, Tai Van, Pham, Hang Thi Nguyet, Nguyen, Phuong Thi, Nguyen, Khoi Minh, Nguyen, Ba Van, and Matsumoto, Kinzo
- Subjects
- *
COGNITION disorders , *MEMORY , *RECOGNITION (Psychology) , *ACETYLCHOLINESTERASE , *ANIMAL experimentation , *LEARNING assessment , *CHOLINESTERASE inhibitors , *GENE expression , *TREATMENT effectiveness , *DEMENTIA , *PLANT extracts , *VASCULAR endothelial growth factors , *DONEPEZIL , *MICE , *MEMORY testing - Abstract
This study aimed to clarify the antidementia effects of ethanolic extract of Ocimum sanctum Linn. (OS) and its underlying mechanisms using olfactory bulbectomized (OBX) mice. OBX mice were treated daily with OS or a reference drug, donepezil (DNP). Spatial and nonspatial working memory performance was measured using a modified Y maze test and a novel object recognition test, respectively. Brain tissues of the animals were subjected to histochemical and neurochemical analysis. OS treatment attenuated OBX-induced impairment of spatial and nonspatial working memories. OBX induced degeneration of septal cholinergic neurons, enlargement of the lateral ventricles, and suppression of hippocampal neurogenesis. OS and DNP treatment also depressed these histological damages. OS administration reduced ex vivo activity of acetylcholinesterase in the brain. OBX diminished the expression levels of genes coding vascular endothelial growth factor (VEGF) and VEGF receptor type 2 (VEGFR2). Treatment with OS and DNP reversed OBX-induced decrease in VEGF gene and protein expression levels without affecting the expression of the VEGFR2 gene. These results demonstrate that the administration of OS can lessen the cognitive deficits and neurohistological damages of OBX and that these actions are, at least in part, mediated by the enhancement of central cholinergic systems and VEGF expression. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
264. New multimodal stationary phases prepared by Ugi multicomponent approach.
- Author
-
Sýkora, David, Záruba, Kamil, Butnariu, Maria, Tatar, Ameneh, Pham, Hang Minh, Studenovský, Martin, Řezanka, Pavel, and Král, Vladimír
- Subjects
- *
CHOLIC acid , *CHEMICAL structure , *MOIETIES (Chemistry) , *RAMAN spectroscopy , *FUNCTIONAL groups - Abstract
Eight different stationary phases based on two aminopropyl silicas of different brands suitable for multimodal chromatography applications have been prepared by a four‐component Ugi reaction. The intention was to synthesize stationary phases significantly differing in their properties hereby demonstrating flexibility of the Ugi synthetic protocol. Diverse functional groups including a nonpolar long aliphatic chain, phenyl moiety, cholic acid scaffold, phenylboronic and monosaccharide units, charged betaine, and arginine moieties were immobilized on a silica surface. The novel sorbents were extensively characterized by elemental analysis, Raman spectroscopy, and chromatography. Considering the anchored chemical structures covalently bonded to the silica surface, reversed‐phase, hydrophilic, and ion‐exchange separation modes were expected. The chromatographic evaluation was performed directed to map the potential of the individual columns specifically in the mentioned chromatographic modes. The Ugi synthetic protocol has proven to be a simple, feasible, and versatile tool for the synthesis of sorbents of variable properties. The newly prepared stationary phases differed considerably in hydrophobicity and ion‐exchange ability. A significant influence of the supporting aminopropyl silica on the final chromatographic behavior was observed. Finally, one practical example confirming applicability of the newly prepared sorbents was demonstrated in separation of cytarabine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
265. Clonotypic IgH Response against Systemic Viral infection in Pronephros and Spleen of a Teleost Fish.
- Author
-
Castro, Rosario, Magadán, Susana, Jouneau, Luc, Mhana, Vanessa, Pham, Hang-Phuong, Mariotti-Ferrandiz, Encarnita, Six, Adrien, Huetz, François, and Boudinot, Pierre
- Subjects
- *
VIRUS diseases , *SPLEEN - Published
- 2023
- Full Text
- View/download PDF
266. Benzofuro[2,3-c]isoquinolines as novel AIEgens: Modulation of AIE characteristics by a single methoxy group.
- Author
-
Kim, Suzi, Park, Jaehyun, Joshi, Dirgha Raj, Lee, Na Keum, Le Bich Pham, Hang, Chung, Linh Khanh, Kang, MinJoo, Kim, Younggwan, Kim, Ikyon, and Lee, Jeeyeon
- Subjects
- *
METHOXY group , *ISOQUINOLINE , *METHOXY compounds , *PHENYL group , *LIGHT scattering , *INTERMOLECULAR interactions - Abstract
Here, we report benzofuro[2,3- c ]isoquinolines (FiQ) as novel blue AIEgens, in which a -OMe group substituent plays a crucial role in modulating intermolecular interactions, inducing a marked increase in emission of up to 150- and 460-fold in the aggregate and solid states, respectively. Our single-crystal X-ray diffraction analysis revealed that the edge-to-face interactions among phenyl groups generate tight networks that rigidify the assembled structures, resulting in AIE. • We developed benzofuro[2,3- c ]isoquinolines as novel fluorophores with AIE characteristics. • Single methoxy group at the C4 position plays a key role in inducing AIE. • The solid-state emission significantly increased in the compounds with the methoxy group at the C4 position. • Dynamic light scattering (DLS) measurements verified the formation of uniform nanoparticles in aqueous solution. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
267. Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule.
- Author
-
Xie, Jinghang, Huang, Xin, Park, Miki S., Pham, Hang M., and Chan, William K.
- Subjects
- *
ARYL hydrocarbon receptors , *CHROMOSOMAL translocation , *ALDOLASES , *TRANSCRIPTION factors , *DIOXINS , *LUCIFERASES , *B cells - Abstract
Abstract: The aryl hydrocarbon receptor (AhR) heterodimerizes with the aryl hydrocarbon receptor nuclear translocator (Arnt) for transcriptional regulation. We generated three N-terminal deletion constructs of the human AhR of 12–24kDa in size – namely D1, D2, and D3 – to suppress the Arnt function. We observed that all three deletions interact with the human Arnt with similar affinities. D2, which contains part of the AhR PAS-A domain and interacts with the PAS-A domain of Arnt, inhibits the formation of the AhR gel shift complex. D2 suppresses the 3-methylcholanthrene-induced, dioxin response element (DRE)-driven luciferase activity in Hep3B cells and exogenous Arnt reverses this D2 suppression. D2 suppresses the induction of CYP1A1 at both the message and protein levels in Hep3B cells; however, the CYP1B1 induction is not affected. D2 suppresses the recruitment of Arnt to the cyp1a1 promoter but not to the cyp1b1 promoter, partly because the AhR/Arnt heterodimer binds better to the cyp1b1 DRE than to the cyp1a1 DRE. Interestingly, D2 has no effect on the cobalt chloride-induced, hypoxia inducible factor-1 (HIF-1)-dependent expression of vegf, aldolase c, and ldh-a messages. Our data reveal that the flanking sequences of the DRE contribute to the binding affinity of the AhR/Arnt heterodimer to its endogenous enhancers and the function of AhR and HIF-1 can be differentially suppressed by the D2 inhibitory molecule. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
268. Development of impact small punch test for investigating energy absorption.
- Author
-
Cao, Bo, Yoshida, Shiguma, Iwamoto, Takeshi, and Pham, Hang Thi
- Subjects
- *
AUSTENITIC stainless steel , *ABSORPTION , *BEND testing , *TRAFFIC accidents , *STRAIN rate - Abstract
• A novel and reliable impact small punch test with high accuracy is developed based on the SHPB technique. • The spatial difference method can improve an accuracy of the measurement on transmitted wave. • A pulse shaper should be introduced to achieve the dynamic equilibrium condition because of a nature of an impedance mismatch on the test. • A reasonable result for an investigation on impact energy absorption of highly-ductile materials is obtained at higher deformation rate. Energy absorption of steel with Transformation-induced Plasticity (TRIP) under bending deformation needs to be carefully examined at very high strain rates for its new applications in the automotive industries. Energy absorption members made of the steel can suppress severe damages by traffic accidents. However, it is difficult to apply three-point bending test based on the split Hopkinson pressure bar (SHPB) method because a use of a thick pre-cracked specimen is required for such materials with high toughness. In contrast, if the impact small punch test, which dominant deformation mode of a relatively-small specimen is bending, is established, its experimental arrangement might become simpler and the SHPB technique is applicable. In this study, a novel and reliable impact small punch testing method based on SHPB technique with high accuracy is developed for an investigation on impact energy absorption of the steel with TRIP. Besides, its design, feasibility and validity are confirmed by finite element simulation for austenitic stainless steel SUS304, a representative of steel with TRIP. The obtained experimental as well as computational results show that the developed testing apparatus for impact small punch test based on SHPB technique is reliable and reasonable for the investigation on impact energy absorption of the high toughness material including steel with TRIP. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
269. Vitamin K[sub 2] Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR.
- Author
-
Tabb, Michelle M., Sun, Aixu, Changcheng Zhou, Grün, Felix, Errandi, Jody, Romero, Kimberly, Pham, Hang, Inoue, Satoshi, Mallick, Shyamali, Li, Min, Forman, Barry M., and Blumberg, Bruce
- Subjects
- *
VITAMIN K , *HOMEOSTASIS , *BONES , *STEROIDS , *XENOBIOTICS - Abstract
Vitamin K[sub 2] is a critical nutrient required for blood clotting that also plays an important role in bone formation. Vitamin K[sub 2] supplementation up-regulates the expression of bone markers, increases bone density in vivo, and is used clinically in the management of osteoporosis. The mechanism of vitamin K[sub 2] action in bone formation was thought to involve its normal role as an essential cofactor for γ-carboxylation of bone matrix proteins. However, there is evidence that suggests vitamin K[sub 2] also has a transcriptional regulatory function. Vitamin K[sub 2] bound to and activated the orphan nuclear receptor SXR and induced expression of the SXR target gene, CYP3A4, identifying it as a bona fide SXR ligand. Vitamin K[sub 2] treatment of osteosarcoma cells increased mRNA levels for the osteoblast markers bone alkaline phosphatase, osteoprotegerin, osteopontin, and matrix Gla protein. The known SXR activators rifampicin and hyperforin induced this panel of bone markers to an extent similar to vitamin K[sub 2]. Vitamin K[sub 2] was able to induce bone markers in primary osteocytes isolated from wild-type murine calvaria but not in cells isolated from mice deficient in the SXR ortholog PXR. We infer that vitamin K[sub 2] is a transcriptional regulator of bonespecific genes that acts through SXR to favor the expression of osteoblastic markers. Thus, SXR has a novel role as a mediator of bone homeostasis in addition to its role as a xenobiotic sensor. An important implication of this work is that a subset of SXR activators may function as effective therapeutic agents for the management of osteoporosis. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
270. Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors.
- Author
-
Bredon M, Danne C, Pham HP, Ruffié P, Bessede A, Rolhion N, Creusot L, Brot L, Alonso I, Langella P, Derosa L, Cortot AB, Routy B, Zitvogel L, Segata N, and Sokol H
- Subjects
- Animals, Humans, Mice, Female, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung immunology, Carcinoma, Non-Small-Cell Lung pathology, Melanoma drug therapy, Melanoma immunology, Melanoma pathology, Feces microbiology, Male, Lung Neoplasms drug therapy, Lung Neoplasms immunology, Lung Neoplasms pathology, Cell Line, Tumor, Mice, Inbred C57BL, Immune Checkpoint Inhibitors pharmacology, Immune Checkpoint Inhibitors therapeutic use, Gastrointestinal Microbiome drug effects, Faecalibacterium prausnitzii drug effects
- Abstract
Gut microbiota impacts responses to immune checkpoint inhibitors (ICI). A high level of Faecalibacterium prausnitzii have been associated with a positive response to ICI in multiple cancer types. Here, based on fecal shotgun metagenomics data, we show in two independent cohorts of patients with non-small cell lung cancer and advanced melanoma that a high level of F. prausnitzii at baseline is positively associated with a better clinical response to ICI. In MCA205 tumor-bearing mice, administration of F. prausnitzii strain EXL01, already in clinical development for Inflammatory Bowel Disease, restores the anti-tumor response to ICI in the context of antibiotic-induced microbiota perturbation at clinical and tumor transcriptomics level. In vitro, EXL01 strain enhances T cell activation in the presence of ICI. Interestingly, oral administration of EXL01 strain did not induce any change in fecal microbiota diversity or composition, suggesting a direct effect on immune cells in the small intestine. F. prausnitzii strain EXL01 will be evaluated as an adjuvant to ICI in multiple cancers in the near future., Competing Interests: HS report lecture fee, board membership, or consultancy from Amgen, Fresenius, IPSEN, Actial, Astellas, Danone, THAC, Biose, BiomX, Eligo, Immusmol, Adare, Nestle, Ferring, MSD, Bledina, Pfizer, Biocodex, BMS, Bromatech, Gilead, Janssen, Mayoli, Roche, Sanofi, Servier, Takeda, Abbvie, has stocks from Enterome bioscience and is co-founder of Exeliom Biosciences. PL report lecture fee, board membership, or consultancy from Biose, Biostime, Boiron, Bonduelle, BMS, Bromatech, IPSEN, iTaK, Lallemand, Lesaffre, L’Oréal, Mayoli, Merck, Procter and Gamble, Second Genome, Therascience and URGO and is co-founder of Exeliom Biosciences. PR is an employee of Exeliom Biosciences. LD was supported by Philantropia Fondation. BR reports grants from Davoltera outside the submitted work, as well as consulting fees from BMS, AstraZeneca, Merck and Davolterra and he is the co-founder of Curebiota. ABC reports lecture fee, board membership, or consultancy from Amgen, Astra-Zeneca, Novartis, Merck KGaA, Pfizer, Roche, Janssen, Abbvie, Sanofi, Takeda, MSD, BMS, InhaTarget and Exeliom. The other authors declare that they have no competing interests., (© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.)
- Published
- 2024
- Full Text
- View/download PDF
271. Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9 -/- mice to colitis.
- Author
-
Danne C, Lamas B, Lavelle A, Michel ML, Da Costa G, Pham HP, Lefevre A, Bridonneau C, Bredon M, Planchais J, Straube M, Emond P, Langella P, and Sokol H
- Subjects
- Animals, Mice, Mice, Knockout, Genetic Predisposition to Disease, Disease Models, Animal, Mice, Inbred C57BL, Colon microbiology, Colon metabolism, Inflammatory Bowel Diseases microbiology, Inflammatory Bowel Diseases genetics, Inflammatory Bowel Diseases immunology, Female, Male, CARD Signaling Adaptor Proteins genetics, Colitis microbiology, Colitis genetics, Colitis immunology, Gastrointestinal Microbiome, Interleukin-22, Pancreatitis-Associated Proteins genetics, Dextran Sulfate, Interleukins genetics, Interleukins metabolism
- Abstract
Background: The etiology of inflammatory bowel disease (IBD) is unclear but involves both genetics and environmental factors, including the gut microbiota. Indeed, exacerbated activation of the gastrointestinal immune system toward the gut microbiota occurs in genetically susceptible hosts and under the influence of the environment. For instance, a majority of IBD susceptibility loci lie within genes involved in immune responses, such as caspase recruitment domain member 9 (Card9). However, the relative impacts of genotype versus microbiota on colitis susceptibility in the context of CARD9 deficiency remain unknown., Results: Card9 gene directly contributes to recovery from dextran sodium sulfate (DSS)-induced colitis by inducing the colonic expression of the cytokine IL-22 and the antimicrobial peptides Reg3β and Reg3γ independently of the microbiota. On the other hand, Card9 is required for regulating the microbiota capacity to produce AhR ligands, which leads to the production of IL-22 in the colon, promoting recovery after colitis. In addition, cross-fostering experiments showed that 5 weeks after weaning, the microbiota transmitted from the nursing mother before weaning had a stronger impact on the tryptophan metabolism of the pups than the pups' own genotype., Conclusions: These results show the role of CARD9 and its effector IL-22 in mediating recovery from DSS-induced colitis in both microbiota-independent and microbiota-dependent manners. Card9 genotype modulates the microbiota metabolic capacity to produce AhR ligands, but this effect can be overridden by the implantation of a WT or "healthy" microbiota before weaning. It highlights the importance of the weaning reaction occurring between the immune system and microbiota for host metabolism and immune functions throughout life. A better understanding of the impact of genetics on microbiota metabolism is key to developing efficient therapeutic strategies for patients suffering from complex inflammatory disorders. Video Abstract., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
272. Kaempferol-3-O-(2″-O-galloyl-β-D-glucopyranoside): a novel neuroprotective agent from Diospryros kaki against cerebral ischemia-induced brain injury.
- Author
-
Nguyen LTT, Le XT, Nguyen HT, Nguyen TV, Pham HNT, Van Thi Pham A, and Matsumoto K
- Subjects
- Mice, Animals, Quercetin pharmacology, Quercetin therapeutic use, Edaravone therapeutic use, Kaempferols pharmacology, Kaempferols therapeutic use, Cerebral Infarction drug therapy, Flavonoids pharmacology, Oxygen, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Diospyros, Brain Ischemia drug therapy, Reperfusion Injury drug therapy, Brain Injuries drug therapy
- Abstract
Our previous study demonstrated neuroprotective and therapeutic effects of a standardized flavonoid extract from leaves of Diospyros kaki L.f. (DK) on middle cerebral artery occlusion-and-reperfusion (MCAO/R)-induced brain injury and its underlying mechanisms. This study aimed to clarify flavonoid components responsible for the effects of DK using in vitro and in vivo transient brain ischemic models. Organotypic hippocampal slice cultures (OHSCs) subjected to oxygen- and glucose-deprivation (OGD) were performed to evaluate in vitro neuroprotective activity of DK extract and nine isolated flavonoid components. MCAO/R mice were employed to elucidate in vivo neuroprotective effects of the flavonoid component that exhibited the most potent neuroprotective effect in OHSCs. DK extract and seven flavonoids [quercetin, isoquercetin, hyperoside, quercetin-3-O-(2″-O-galloyl-β-D-galactopyranoside), kaempferol, astragalin, and kaempferol-3-O-(2″-O-galloyl-β-D-glucopyranoside) compound (9)] attenuated OGD-induced neuronal cell damage and compound (9) possessed the most potent neuroprotective activity in OHSCs. The MCAO/R mice showed cerebral infarction, massive weight loss, characteristic neurological symptoms, and deterioration of neuronal cells in the brain. Compound (9) and a reference drugs, edaravone, significantly attenuated these physical and neurological impairments. Compound (9) mitigated the blood-brain barrier dysfunction and the change of glutathione and malondialdehyde content in the MCAO mouse brain. Edaravone suppressed the oxidative stress but did not significantly affect the blood-brain barrier permeability. The present results indicated that compound (9) is a flavonoid constituent of DK with a potent neuroprotective activity against transient ischemia-induced brain damage and this action, at least in part, via preservation of blood-brain barrier integrity and suppression of oxidative stress caused by ischemic insult., (© 2023. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.)
- Published
- 2024
- Full Text
- View/download PDF
273. Therapeutic effects of a standardized-flavonoid Diospyros kaki L.f. leaf extract on transient focal cerebral ischemia-induced brain injury in mice.
- Author
-
Nguyen LTT, Le XT, Pham HNT, Van Nguyen T, Nguyen PT, Van Thi Pham A, Nguyen TBT, and Matsumoto K
- Subjects
- Mice, Animals, Flavonoids pharmacology, Vascular Endothelial Growth Factor A, Infarction, Middle Cerebral Artery drug therapy, Infarction, Middle Cerebral Artery complications, Infarction, Middle Cerebral Artery metabolism, Apoptosis, Plant Extracts pharmacology, Plant Extracts therapeutic use, Diospyros, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Brain Ischemia drug therapy, Brain Ischemia complications, Brain Ischemia metabolism, Brain Injuries complications, Brain Injuries drug therapy, Reperfusion Injury drug therapy
- Abstract
This study aimed to investigate the neuroprotective and therapeutic effects of Diospyros kaki L.f. leaves (DK) on transient focal cerebral ischemic injury and underlying mechanisms using a middle cerebral artery occlusion (MCAO) model of mice. The animals received the MCAO operation on day 0. The daily administrations of DK (50 and 100 mg/kg, p.o) and edaravone (6 mg/kg, i.v), a reference drug with radical scavenging activity, were started 7 days before (pre-treatment) or immediately after the MCAO operation (post-treatment) and continued during the experimental period. Histochemical, biochemical, and neurological changes and cognitive performance were evaluated. MCAO caused cerebral infarction and neuronal cell loss in the cortex, striatum, and hippocampus in a manner accompanied by spatial cognitive deficits. These neurological and cognitive impairments caused by MCAO were significantly attenuated by pre- and post-ischemic treatments with DK and edaravone, suggesting that DK, like edaravone, has therapeutic potential for cerebral ischemia-induced brain damage. DK and edaravone suppressed MCAO-induced changes in biomarkers for apoptosis (TUNEL-positive cell number and cleaved caspase-3 protein expression) and oxidative stress (glutathione and malondialdehyde contents) in the brain. Interestingly, DK, but not edaravone, mitigated an increase in blood-brain permeability and down-regulation of vascular endothelial growth factor protein expression caused by MCAO. Although the exact chemical constituents implicated in the effects of DK remain to be clarified, the present results indicate that DK exerts neuroprotective and therapeutic activity against transient focal cerebral ischemia-induced injury probably by suppressing oxidative stress, apoptotic process, and mechanisms impairing blood-brain barrier integrity in the brain., (© 2023. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.)
- Published
- 2023
- Full Text
- View/download PDF
274. Detection and assessment of risk factors associated with Newcastle disease virus infection in birds in backyard poultry in Laichau province of Vietnam.
- Author
-
Pham HM and Do TT
- Subjects
- Animals, Newcastle disease virus genetics, Poultry, Chickens, Vietnam, Seroepidemiologic Studies, Animals, Wild, Risk Factors, Newcastle Disease, Poultry Diseases
- Abstract
Newcastle disease (ND) is a highly pathogenic and contagious viral infectious disease of poultry that causes a very serious problem for poultry production and economic loss worldwide. ND has been an epizootic disease in Vietnam. Information about the risk factors that are associated with virus transmission in backyard chickens in Vietnam is limited. To provide more epidemiological information about ND in Vietnam, this study was performed to estimate NDV prevalence and identify the risk factors for ND virus (NDV) infection in birds at the backyard flock level. Choanal swabs were taken from 400 randomly selected birds from 100 apparently healthy flocks from May to July 2020. Based on RT-PCR analysis, 43 of 400 swab samples (10.75%; 95% CI 8-14.17) and 21 of 100 flocks (21%; 95% CI 14.17-29.98) were positive for the fusion (F) gene of NDV. The management practice risks were: backyard flocks contacting wild birds (OR = 3.89; P = 0.030), mixed flocks with different types and species of birds (OR = 5.46; P = 0.004), and infrequency of cleaning and disinfecting poultry houses (OR (odds ratio) = 4.43; P = 0.034). The second and third risks (above) showed a positive interaction on the risk of NDV infection in birds (OR = 39.38; P = 0.001), and the first risk showed a negative interaction. Further studies on NDV surveillance in domestic waterfowl, longitudinal studies, a well-optimized RT-qPCR assay, and genetic characterization are needed. The development of handbooks, flyers, or lessons for educating poultry keepers are also needed. RESEARCH HIGHLIGHT RT-PCR was used to detect the F gene of NDV in choanal swabs.Risk factors associated with NDV-positive samples were determined.The evidence for NDV circulation in backyard healthy birds was observed.Contact with wild birds, mixed flocks, and poor hygiene were major risk factors.
- Published
- 2023
- Full Text
- View/download PDF
275. Human thymopoiesis produces polyspecific CD8 + α/β T cells responding to multiple viral antigens.
- Author
-
Quiniou V, Barennes P, Mhanna V, Stys P, Vantomme H, Zhou Z, Martina F, Coatnoan N, Barbie M, Pham HP, Clémenceau B, Vie H, Shugay M, Six A, Brandao B, Mallone R, Mariotti-Ferrandiz E, and Klatzmann D
- Subjects
- Humans, Receptors, Antigen, T-Cell, alpha-beta genetics, Receptors, Antigen, T-Cell genetics, Peptides, CD8-Positive T-Lymphocytes, Antigens, Viral genetics
- Abstract
T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10
19 sequences. They are selected during thymopoiesis, which releases a repertoire of about 108 unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively handle a countless and evolving set of infectious agents is a central question of immunology. The paradigm is that a diverse enough repertoire of TCRs should always provide a proper, though rare, specificity for any given need. Expansion of such rare T cells would provide enough fighters for an effective immune response and enough antigen-experienced cells for memory. We show here that human thymopoiesis releases a large population of clustered CD8+ T cells harboring α/β paired TCRs that (i) have high generation probabilities and (ii) a preferential usage of some V and J genes, (iii) which CDR3 are shared between individuals, and (iv) can each bind and be activated by multiple unrelated viral peptides, notably from EBV, CMV, and influenza. These polyspecific T cells may represent a first line of defense that is mobilized in response to infections before a more specific response subsequently ensures viral elimination. Our results support an evolutionary selection of polyspecific α/β TCRs for broad antiviral responses and heterologous immunity., Competing Interests: VQ Valentin Quiniou is affiliated with Parean biotechnologies. The author has no financial interests to declare, PB, VM, PS, HV, ZZ, FM, NC, MB, BC, HV, MS, AS, BB, RM, EM, DK No competing interests declared, HP Hang-Phuong Pham is affiliated with ILTOO pharma and Parean biotechnologies. The author hasno financial interests to declare, (© 2023, Quiniou et al.)- Published
- 2023
- Full Text
- View/download PDF
276. Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.
- Author
-
Coney JM, Zubricky R, Sinha SB, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, McCoy J, and Karcher H
- Abstract
Background: The anti-vascular endothelial growth factor (anti-VEGF) injection interval influences treatment burden and compliance in neovascular age-related macular degeneration (nAMD). This real-world study investigates visual acuity (VA), injection-interval extension, central macular thickness (CMT) and safety in nAMD eyes switched to the anti-VEGF agent brolucizumab and followed for up to 18 months., Methods: This retrospective study included patients with nAMD who were switched from other anti-VEGF agents to brolucizumab only. Patient eyes were grouped into three nested cohorts with the overall cohort receiving ≥ 1 brolucizumab injection, the second receiving ≥ 3 brolucizumab injections with a follow-up period of ≥ 12 months and the third cohort receiving ≥ 3 brolucizumab injections with a follow-up period of ≥ 18 months. Study endpoints included changes from baseline at 12 or 18 months in VA, injection intervals, and CMT. Sub-group analyses were conducted using baseline injection interval length or baseline VA as qualifiers., Results: Overall, 482 eyes received ≥ 1 brolucizumab injection; 174 eyes received ≥ 3 brolucizumab injections with ≥ 12 months of follow-up, and 95 eyes received ≥ 3 brolucizumab injections with ≥ 18 months of follow-up. VA (mean [95% confidence intervals]) remained stable relative to baseline after 12 months (- 1.1 [- 3.7, 1.6] letters; p = 0.42) and 18 months (0.0 [- 3.1, 3.1] letters; p = 0.98) of brolucizumab treatment, respectively, and pre-switch injection intervals or baseline VA had no notable effect. Following the switch to brolucizumab, injection intervals were extended from baseline to month 12 by 26.9 (19.7, 34.0) days (p < 0.0001), and eyes with pre-switch injection intervals < 8 weeks were able to have their injection intervals extended by 23.6 days longer than eyes with pre-switch injection intervals ≥ 8 weeks. At 18 months, injection intervals were extended by 36.3 (25.6, 46.9) days (p < 0.0001) compared to baseline. Following switch to brolucizumab, CMT was reduced at both 12 and 18 months (12 months: - 35.2 (- 51.7, - 18.8) µm, p < 0.0001; 18 months: - 38.9 (- 54.3, - 22.0) µm, p < 0.0001). Intraocular inflammation-related adverse events were reported in 4.6% of brolucizumab-treated eyes., Conclusions: This real-world study demonstrates that injection intervals may be significantly extended with maintained vision and reduced CMT in nAMD eyes switching to brolucizumab therapy from other anti-VEGFs., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
277. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial.
- Author
-
Humrich JY, Cacoub P, Rosenzwajg M, Pitoiset F, Pham HP, Guidoux J, Leroux D, Vazquez T, Riemekasten G, Smolen JS, Tsokos G, and Klatzmann D
- Subjects
- Humans, Severity of Illness Index, Immunologic Factors therapeutic use, Double-Blind Method, Treatment Outcome, Interleukin-2 therapeutic use, Lupus Erythematosus, Systemic
- Abstract
Objectives: A regulatory T cell (Treg) insufficiency due to shortage of interleukin-2 (IL-2) is central to the pathophysiology of systemic lupus erythematosus (SLE). We performed a multicentre, double-blinded, randomised, placebo-controlled phase II proof-of-concept trial to evaluate the efficacy of low-dose IL-2 therapy in patients with SLE having moderate-to-severe disease activity while receiving standard treatment., Methods: We randomly assigned 100 patients in a 1:1 ratio to receive either 1.5 million IU/day of subcutaneous IL-2 (ILT-101) or placebo for 5 days followed by weekly injections for 12 weeks. Clinical efficacy was assessed at week 12 in a predefined hierarchical analysis of (1) the SLE responder index-4 (SRI-4) response as a primary end point, and of (2) relative and (3) absolute changes in the Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index scores as key secondary end points., Results: The primary end point was not met in the intention-to-treat population (ILT-101: 68%, placebo: 58%; p=0.3439), due to a 100% SRI-4 response rate in the placebo group from the two sites from Bulgaria. A post hoc per-protocol analysis on a prespecified population that excluded patients from these two sites (n=53) showed a statistically significant difference for the SRI-4 response rate (ILT-101: 83.3%; placebo: 51.7%; p=0.0168), and for the two key secondary end points, accompanied by differences in several secondary exploratory end points. ILT-101 was well tolerated and there was no generation of antidrug antibodies., Conclusions: The post hoc hierarchical analysis of the primary and key secondary end points in a per-protocol population, complemented by the exploratory analyses of multiple other secondary end points, support that low-dose IL-2 is beneficial in active SLE., Trial Registration Number: NCT02955615., Competing Interests: Competing interests: PC, MR and DK are inventors for patents related to the therapeutic use of IL-2, which belongs to their academic institutions and have been licensed to ILTOO Pharma in which they hold interests. HPP, JG, DL and TV are employees of ILTOO Pharma., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
278. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
- Author
-
Benhamouda N, Sam I, Epaillard N, Gey A, Phan L, Pham HP, Gruel N, Saldmann A, Pineau J, Hasan M, Quiniou V, Nevoret C, Verkarre V, Libri V, Mella S, Granier C, Broudin C, Ravel P, De Guillebon E, Mauge L, Helley D, Jabla B, Chaput N, Albiges L, Katsahian S, Adam J, Mejean A, Adotevi O, Vano YA, Oudard S, and Tartour E
- Subjects
- Humans, CD27 Ligand genetics, Tumor Necrosis Factor Receptor Superfamily, Member 7 genetics, Immunotherapy, Tumor Microenvironment, Carcinoma, Renal Cell drug therapy, Carcinoma, Renal Cell genetics, Kidney Neoplasms drug therapy, Kidney Neoplasms genetics
- Abstract
Purpose: CD70 is a costimulatory molecule known to activate CD27-expressing T cells. CD27-CD70 interaction leads to the release of soluble CD27 (sCD27). Clear-cell renal cell carcinoma (ccRCC) expresses the highest levels of CD70 among all solid tumors; however, the clinical consequences of CD70 expression remain unclear., Experimental Design: Tumor tissue from 25 patients with ccRCC was assessed for the expression of CD27 and CD70 in situ using multiplex immunofluorescence. CD27+ T-cell phenotypes in tumors were analyzed by flow cytometry and their gene expression profile were analyzed by single-cell RNA sequencing then confirmed with public data. Baseline sCD27 was measured in 81 patients with renal cell carcinoma (RCC) treated with immunotherapy (35 for training cohort and 46 for validation cohort)., Results: In the tumor microenvironment, CD27+ T cells interacted with CD70-expressing tumor cells. Compared with CD27- T cells, CD27+ T cells exhibited an apoptotic and dysfunctional signature. In patients with RCC, the intratumoral CD27-CD70 interaction was significantly correlated with the plasma sCD27 concentration. High sCD27 levels predicted poor overall survival in patients with RCC treated with anti-programmed cell death protein 1 in both the training and validation cohorts but not in patients treated with antiangiogenic therapy., Conclusions: In conclusion, we demonstrated that sCD27, a surrogate marker of T-cell dysfunction, is a predictive biomarker of resistance to immunotherapy in RCC. Given the frequent expression of CD70 and CD27 in solid tumors, our findings may be extended to other tumors., (©2022 American Association for Cancer Research.)
- Published
- 2022
- Full Text
- View/download PDF
279. Polyphasic evaluation and cytotoxic investigation of isolated cyanobacteria with an emphasis on potent activities of a Scytonema strain.
- Author
-
Ngo TT, Nguyen BT, Duong TA, Nguyen TT, Nguyen TL, Kieu KT, Do MT, Nguyen SV, Thang ND, and Pham HTL
- Abstract
Cyanobacteria are phototrophic organisms widely found in most types of natural habitats in the tropical regions of the world. In this study, we isolated and identified cyanobacterial strains from paddy soil in Hanoi (Vietnam) and investigated their cytotoxic activities. Five isolated cyanobacterial strains showed distinctive profiles of gene sequences (rRNA 16S and rbcL ), phylogenetic placements, and morphological characteristics. Based on the polyphasic evaluation, they were classified as Scytonema bilaspurense NK13, Hapalosiphon welwitschii MD2411, Aulosira sp. XN1103, Desikacharya sp. NS2000, and Desmonostoc sp. NK1813. The cytotoxic screening revealed that the extract of strain Scytonema bilaspurense NK13 exhibited potent cytotoxic activities against four human cell lines of HeLa cells, OVCAR-8 cells, HaCaT cells, and HEK-293T cells, with IC
50 values of 3.8, 34.2, 21.6, and 0.6 μg/mL, respectively. This is the first time a well-classified Scytonema strain from tropical habitat in Southeast Asia has been recognized as a potential producer of cytotoxic compounds., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Ngo, Nguyen, Duong, Nguyen, Nguyen, Kieu, Do, Nguyen, Thang and Pham.)- Published
- 2022
- Full Text
- View/download PDF
280. Target Capture Reveals the Complex Origin of Vietnamese Ginseng.
- Author
-
Le HTT, Nguyen LN, Pham HLB, Le HTM, Luong TD, Huynh HTT, Nguyen VT, Nong HV, Teixidor-Toneu I, De Boer HJ, and Manzanilla V
- Abstract
The global market of the medicinal plant ginseng is worth billions of dollars. Many ginseng species are threatened in the wild and effective sustainable development initiatives are necessary to preserve biodiversity at species and genetic level whilst meeting the demand for medicinal produce. This is also the case of Panax vietnamensis Ha & Grushv., an endemic and threatened ginseng species in Vietnam that is locally cultivated at different scales and has been the object of national breeding programs. To investigate the genetic diversity within cultivated and wild populations of P. vietnamensis we captured 353 nuclear markers using the Angiosperm-353 probe set. Genetic diversity and population structure were evaluated for 319 individuals of Vietnamese ginseng across its area of distribution and from wild and a varying range of cultivated areas. In total, 319 individuals were sampled. After filtering, 1,181 SNPs were recovered. From the population statistics, we observe high genetic diversity and high genetic flow between populations. This is also supported by the STRUCTURE analysis. The intense gene flow between populations and very low genetic differentiation is observed regardless of the populations' wild or cultivated status. High levels of admixture from two ancestral populations exist in both wild and cultivated samples. The high gene flow between populations can be attributed to ancient and on-going practices of cultivation, which exist in a continuum from understorey, untended breeding to irrigated farm cultivation and to trade and exchange activities. These results highlight the importance of partnering with indigenous peoples and local communities and taking their knowledge into account for biodiversity conservation and sustainable development of plants of high cultural value., Competing Interests: VM was employed by Baseclear BV. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Le, Nguyen, Pham, Le, Luong, Huynh, Nguyen, Nong, Teixidor-Toneu, De Boer and Manzanilla.)
- Published
- 2022
- Full Text
- View/download PDF
281. Clonotypic IgH Response against Systemic Viral infection in Pronephros and Spleen of a Teleost Fish.
- Author
-
Castro R, Magadán S, Jouneau L, Mhana V, Pham HP, Mariotti-Ferrandiz E, Six A, Huetz F, and Boudinot P
- Subjects
- Animals, Spleen, Fish Diseases, Hemorrhagic Septicemia, Viral prevention & control, Novirhabdovirus, Oncorhynchus mykiss genetics, Pronephros, Virus Diseases
- Abstract
Upon infection, B lymphocytes develop clonal responses. In teleost fish, which lack lymph nodes, the kinetics and location of B cell responses remain poorly characterized. Fish pronephros is the site of B cell differentiation and the main niche for persistence of plasma cells. In this study, we undertook the analysis of the rainbow trout IgHμ repertoire in this critical tissue for humoral adaptive immunity after primary immunization and boost with a rhabdovirus, the viral hemorrhagic septicemia virus (VHSV). We used a barcoded 5' RACE-cDNA sequencing approach to characterize modifications of the IgHμ repertoire, including VH usage in expressed V(D)J rearrangements, clonal diversity, and clonotype sharing between individual fish and treatments. In the pronephros, our approach quantified the clonotype frequency across the whole IgH repertoire (i.e., with all VH), measuring the frequency of Ag-responding clonotypes. Viral infection led to extensive modifications of the pronephros B cell repertoire, implicating several VH subgroups after primary infection. In contrast, only modest changes in repertoire persisted 5 mo later, including VHSV-specific public expansions. The IgM public response implicating IgHV1-18 and JH5, previously described in spleen, was confirmed in pronephros in all infected fish, strongly correlated to the response. However, the distribution of top clonotypes showed that pronephros and spleen B cells constitute distinct compartments with different IgH repertoires. Unexpectedly, after boost, the frequency of anti-VHSV clonotypes decreased both in pronephros and spleen, raising questions about B cell circulation. A better monitoring of B cell response kinetics in lymphoid tissues will be an essential step to understand B memory and plasmocyte formation mechanisms in fish., (Copyright © 2022 by The American Association of Immunologists, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
282. Ursolic acid and its isomer oleanolic acid are responsible for the anti-dementia effects of Ocimum sanctum in olfactory bulbectomized mice.
- Author
-
Nguyen HT, Le XT, Van Nguyen T, Phung HN, Pham HTN, Nguyen KM, and Matsumoto K
- Subjects
- Acetylcholinesterase, Animals, Donepezil, Mice, Olfactory Bulb surgery, Plant Extracts pharmacology, Plant Extracts therapeutic use, Triterpenes, Vascular Endothelial Growth Factor A, Ursolic Acid, Ocimum sanctum, Oleanolic Acid pharmacology, Oleanolic Acid therapeutic use
- Abstract
This study aims to clarify the bioactive constituents responsible for the anti-dementia effects of Ocimum sanctum Linn. ethanolic extract (OS) using olfactory bulbectomized (OBX) mice, an animal model of dementia. The effects of OS or its extract further fractionated with n-hexane (OS-H), ethyl acetate (OS-E), and n-butanol (OS-B) on the spatial cognitive deficits of OBX mice were elucidated by the modified Y-maze tests. The effects of the major constituents of the most active OS fraction were also elucidated using the reference drug donepezil. The administration of OS and OS-E ameliorated the spatial cognitive deficits caused by OBX, whereas OS-H or OS-B had no effect. Two major constituents, ursolic acid (URO) and oleanolic acid (OLE), and three minor constituents were isolated from OS-E. URO (6 and 12 mg/kg) and OLE (24 mg/kg) attenuated the OBX-induced cognitive deficits. URO (6 mg/kg) and donepezil reversed the OBX-induced down-regulation of vascular endothelial growth factor (VEGF) and choline acetyltransferase expression levels in the hippocampus. URO inhibited the ex vivo activity of acetylcholinesterase with similar efficacy to donepezil. URO inhibited the in vitro activity of acetylcholinesterase (IC
50 = 106.5 μM), while the effects of OS, OS-E, and other isolated compounds were negligible. These findings suggest that URO and OLE are responsible for the anti-dementia action of OS extract, whereas URO possesses a more potent anti-dementia effect than its isomer OLE. The effects of URO are, at least in part, mediated by normalizing the function of central cholinergic systems and VEGF protein expression., (© 2022. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.)- Published
- 2022
- Full Text
- View/download PDF
283. Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial.
- Author
-
Nguyen TP, Do Q, Phan LT, Dinh DV, Khong H, Hoang LV, Nguyen TV, Pham HN, Chu MV, Nguyen TT, Pham QD, Le TM, Trang TNT, Dinh TT, Vo TV, Vu TT, Nguyen QBP, Phan VT, Nguyen LV, Nguyen GT, Tran PM, Nghiem TD, Tran TV, Nguyen TG, Tran TQ, Nguyen LT, Do AT, Nguyen DD, Ho SA, Nguyen VT, Pham DT, Tran HB, Vu ST, Hoang SX, Do TM, Nguyen XT, Le GQ, Tran T, Cao TM, Dao HM, Nguyen TTT, Doan UY, Le VTT, Tran LP, Nguyen NM, Nguyen NT, Pham HTT, Nguyen QH, Nguyen HT, Nguyen HLK, Tran VT, Tran MTN, Nguyen TTT, Ha PT, Huynh HT, Nguyen KD, Thuan UT, Doan CC, and Do SM
- Abstract
Background: Nanocovax is a recombinant severe acute respiratory syndrome coronavirus 2 subunit vaccine composed of full-length prefusion stabilized recombinant SARS-CoV-2 spike glycoproteins (S-2P) and aluminium hydroxide adjuvant., Methods: We conducted a dose-escalation, open label trial (phase 1) and a randomized, double-blind, placebo-controlled trial (phase 2) to evaluate the safety and immunogenicity of the Nanocovax vaccine (in 25 mcg, 50 mcg, and 75 mcg doses, aluminium hydroxide adjuvanted (0·5 mg/dose) in 2-dose regime, 28 days apart (ClinicalTrials.gov number, NCT04683484). In phase 1, 60 participants received two intramuscular injection of the vaccine following dose-escalation procedure. The primary outcomes were reactogenicity and laboratory tests to evaluate the vaccine safety. In phase 2, 560 healthy adults received either vaccine doses similar in phase 1 (25 or 50 or 75 mcg S antigen in 0·5 mg aluminium per dose) or adjuvant (0·5 mg aluminium) in a ratio of 2:2:2:1. One primary outcome was the vaccine safety, including solicited adverse events for 7 day and unsolicited adverse events for 28 days after each injection as well as serious adverse event or adverse events of special interest throughout the study period. Another primary outcome was anti-S IgG antibody response (Index unit/ml). Secondary outcomes were surrogate virus neutralisation (inhibition percentage), wild-type SARS-CoV-2 neutralisation (dilution fold), and T-cell responses by intracellular staining for interferon gamma (IFNg). Anti-S IgG and neutralising antibody levels were compared with convalescent serum samples from symptomatic Covid-19 patients., Findings: For phase 1 study, no serious adverse events were observed for all 60 participants. Most adverse events were grade 1 and disappeared shortly after injection. For phase 2 study, after randomisation, 480 participants were assigned to receive the vaccine with adjuvant, and 80 participants were assigned to receive the placebo (adjuvant only). Reactogenicity was absent or mild in the majority of participants and of short duration (mean ≤3 days). Unsolicited adverse events were mild in most participants. There were no serious adverse events related to Nanocovax. Regarding the immunogenicity, Nanocovax induced robust anti-S antibody responses. In general, there humoral responses were similar among vaccine groups which reached their peaks at day 42 and declined afterward. At day 42, IgG levels of vaccine groups were 60·48 [CI95%: 51·12-71·55], 49·11 [41·26-58·46], 57·18 [48·4-67·5] compared to 7·10 [6·32-13·92] of convalescent samples. IgG levels reported here can be converted to WHO international standard binding antibody unit (BAU/ml) by multiplying them to a conversion factor of 21·8. Neutralising antibody titre of vaccine groups at day 42 were 89·2 [52·2-152·3], 80·0 [50·8-125.9] and 95·1 [63·1-143·6], compared to 55·1 [33·4-91·0] of the convalescent group., Interpretation: Up to day 90, Nanocovax was found to be safe, well tolerated, and induced robust immune responses., Funding: This work was funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the Ministry of Science and Technology of Vietnam, and Nanogen Pharmaceutical Biotechnology JSC., Competing Interests: TPN, HK, TML, TTNT, TTD, TVV, TTTV, QBPN, VTP, VTT, MTNT, TTTN, PTH, HTH, KDN, CCD, TTU, SMD are employees of Nanogen Pharmaceutical Biotechnology JSC. MTNT, and SMD are authors of a pending patent for Nanocovax., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
284. Chemical constituents and absolute configuration of megastigmanes' isolated from Sedum sarmentosum Bunge.
- Author
-
Doan DX, Sun S, Omar AM, Nguyen DT, Hoang ALT, Fujiwara H, Matsumoto K, Pham HTN, and Awale S
- Subjects
- Humans, Norisoprenoids chemistry, Phytochemicals, Antineoplastic Agents, Drugs, Chinese Herbal chemistry, Sedum chemistry
- Abstract
Phytochemical investigation of a methanolic extract of Sedum sarmentosum collected from Vietnam resulted in the isolation of a new megastigmane glucoside, named sedumoside K ( 1 ), together with 17 previously reported compounds ( 2-18 ). Structural elucidation of the new compound was achieved by HRFABMS, NMR spectroscopic analysis, acid hydrolysis and quantum ECD calculations. The absolute configuration of compounds 2-6 has been revised. The major isolates were tested for cytotoxic activity against HeLa human cervical cancer cells, and all showed moderate activities.
- Published
- 2022
- Full Text
- View/download PDF
285. The Tsallis generalized entropy enhances the interpretation of transcriptomics datasets.
- Author
-
Dérian N, Pham HP, Nehar-Belaid D, Tchitchek N, Klatzmann D, Eric V, and Six A
- Subjects
- Animals, Entropy, Mice, Ecology, Transcriptome
- Abstract
Background: Identifying differentially expressed genes between experimental conditions is still the gold-standard approach to interpret transcriptomic profiles. Alternative approaches based on diversity measures have been proposed to complement the interpretation of such datasets but are only used marginally., Methods: Here, we reinvestigated diversity measures, which are commonly used in ecology, to characterize mice pregnancy microenvironments based on a public transcriptome dataset. Mainly, we evaluated the Tsallis entropy function to explore the potential of a collection of diversity measures for capturing relevant molecular event information., Results: We demonstrate that the Tsallis entropy function provides additional information compared to the traditional diversity indices, such as the Shannon and Simpson indices. Depending on the relative importance given to the most abundant transcripts based on the Tsallis entropy function parameter, our approach allows appreciating the impact of biological stimulus on the inter-individual variability of groups of samples. Moreover, we propose a strategy for reducing the complexity of transcriptome datasets using a maximation of the beta diversity., Conclusions: We highlight that a diversity-based analysis is suitable for capturing complex molecular events occurring during physiological events. Therefore, we recommend their use through the Tsallis entropy function to analyze transcriptomics data in addition to differential expression analyses., Competing Interests: The authors do not declare any conflict of interest.
- Published
- 2022
- Full Text
- View/download PDF
286. Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer.
- Author
-
Terrisse S, Goubet AG, Ueda K, Thomas AM, Quiniou V, Thelemaque C, Dunsmore G, Clave E, Gamat-Huber M, Yonekura S, Ferrere G, Rauber C, Pham HP, Fahrner JE, Pizzato E, Ly P, Fidelle M, Mazzenga M, Costa Silva CA, Armanini F, Pinto F, Asnicar F, Daillère R, Derosa L, Richard C, Blanchard P, Routy B, Culine S, Opolon P, Silvin A, Ginhoux F, Toubert A, Segata N, McNeel DG, Fizazi K, Kroemer G, and Zitvogel L
- Subjects
- Androgen Antagonists pharmacology, Androgen Antagonists therapeutic use, Androgens therapeutic use, Animals, Humans, Immune System, Male, Mice, Gastrointestinal Microbiome, Prostatic Neoplasms, Castration-Resistant drug therapy
- Abstract
Background: Prostate cancer (PC) responds to androgen deprivation therapy (ADT) usually in a transient fashion, progressing from hormone-sensitive PC (HSPC) to castration-resistant PC (CRPC). We investigated a mouse model of PC as well as specimens from PC patients to unravel an unsuspected contribution of thymus-derived T lymphocytes and the intestinal microbiota in the efficacy of ADT., Methods: Preclinical experiments were performed in PC-bearing mice, immunocompetent or immunodeficient. In parallel, we prospectively included 65 HSPC and CRPC patients (Oncobiotic trial) to analyze their feces and blood specimens., Results: In PC-bearing mice, ADT increased thymic cellularity and output. PC implanted in T lymphocyte-depleted or athymic mice responded less efficiently to ADT than in immunocompetent mice. Moreover, depletion of the intestinal microbiota by oral antibiotics reduced the efficacy of ADT. PC reduced the relative abundance of Akkermansia muciniphila in the gut, and this effect was reversed by ADT. Moreover, cohousing of PC-bearing mice with tumor-free mice or oral gavage with Akkermansia improved the efficacy of ADT. This appears to be applicable to PC patients because long-term ADT resulted in an increase of thymic output, as demonstrated by an increase in circulating recent thymic emigrant cells (sjTRECs). Moreover, as compared with HSPC controls, CRPC patients demonstrated a shift in their intestinal microbiota that significantly correlated with sjTRECs. While feces from healthy volunteers restored ADT efficacy, feces from PC patients failed to do so., Conclusions: These findings suggest the potential clinical utility of reversing intestinal dysbiosis and repairing acquired immune defects in PC patients., Competing Interests: Competing interests: LZ and GK are scientific cofounders of everImmune, a company that develops bacteria for the treatment of cancer. GK is a scientific cofounder of Samsara Therapeutics and Therafast Bio. Acknowledgments: LZ laboratory was supported by the Germano-French ANR Ileobiome—19-CE15-0029-01 and H2020 ONCOBIOME N°825410, RHU Torino Lumière ANR-16-RHUS-0008; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE). GK is supported by Agence Nationale de la Recherche (ANR)—Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association 'Ruban Rose'; Cancéropôle Ile-de-France; Fondation pour la Recherche Médicale (FRM); a donation by Elior; Equipex Onco-Pheno-Screen; European Joint Programme on Rare Diseases (EJPRD); Gustave Roussy Odyssea, the European Union Horizon 2020 Projects Oncobiome and Crimson; Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); the Leducq Foundation; the and SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Université de Paris ANR-18-IDEX-0001. AMT and EC are supported by the French Government’s Investissement d’Avenir Program, Laboratoire d’Excellence 'Milieu Intérieur' Grant ANR-10-LABX-69-01. INSERM U.1160 is a member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia. MG-H and DGM are supported by the grant funding NIH/NCI P01 CA250927., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
287. The SALT-Readout ASIC for Silicon Strip Sensors of Upstream Tracker in the Upgraded LHCb Experiment.
- Author
-
Abellan Beteta C, Andreou D, Artuso M, Beiter A, Blusk S, Bugiel R, Bugiel S, Carbone A, Carli I, Chen B, Conti N, De Benedetti F, Ding S, Ely S, Firlej M, Fiutowski T, Gandini P, Germann D, Grieser N, Idzik M, Jiang X, Krupa W, Li Y, Li Z, Liang X, Liu S, Lu Y, Mackey L, Moron J, Mountain R, Petruzzo M, Pham H, Schmidt B, Sheng S, Spadaro Norella E, Swientek K, Szumlak T, Tobin M, Wang J, Wilkinson M, Wu H, Zhang F, and Zou Q
- Abstract
SALT, a new dedicated readout Application Specific Integrated Circuit (ASIC) for the Upstream Tracker, a new silicon detector in the Large Hadron Collider beauty (LHCb) experiment, has been designed and developed. It is a 128-channel chip using an innovative architecture comprising a low-power analogue front-end with fast pulse shaping and a 40 MSps 6-bit Analog-to-Digital Converter (ADC) in each channel, followed by a Digital Signal Processing (DSP) block performing pedestal and Mean Common Mode (MCM) subtraction and zero suppression. The prototypes of SALT were fabricated and tested, confirming the full chip functionality and fulfilling the specifications. A signal-to-noise ratio of about 20 is achieved for a silicon sensor with a 12 pF input capacitance. In this paper, the SALT architecture and measurements of the chip performance are presented.
- Published
- 2021
- Full Text
- View/download PDF
288. In Vitro Antiviral Activity of Green Tea Polyphenon-60 against Avian Paramyxoviruses.
- Author
-
Pham HM
- Abstract
Avian paramyxoviruses (APMVs) have caused an economically significant drop in global domestic poultry production because of their high morbidity and mortality rates. Polyphenols are the major components of green tea that have great antiviral effects. This study aimed to evaluate the anti-APMV activities of polyphenon-60. Twelve APMV-1 strains representing three different pathotypes, two strains of APMV-2, one strain of APMV-3, and one strain of APMV-7 were propagated in chicken embryos. To determine the cytotoxic effect, chicken embryo fibroblasts were treated with the test compound in various concentrations. To assess the antiviral properties, time-dependent, dose-dependent, and virulence-dependent experiments were conducted in both cell and chicken embryo models. A reduction in virus titers was measured by the hemagglutination test. The inhibitory effect on virus adsorption to the chicken red blood cell (RBC) surface was examined by the hemagglutination inhibition test. The results showed that lentogenic and mesogenic APMV-1 strains, APMV-3 strain, and APMV-7 strain were significantly inhibited ( p < 0.05) by polyphenon-60 at 50 μ g/ml, while the 50% cytotoxic concentration of the compound was 345 μ g/ml. Polyphenon-60 also exhibited the inhibitory activity against hemagglutination by NDV. Taken together, the results suggest that polyphenon-60 has shown promise as an antiviral agent that has wide safety margins against APMVs, and challenge studies to evaluate its efficacy in chickens are necessary., Competing Interests: The author declares that there are no conflicts of interest regarding the publication of this paper., (Copyright © 2021 Hang Minh Pham.)
- Published
- 2021
- Full Text
- View/download PDF
289. Genome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: Understanding the nature of the epidemic and role of the D614G mutation.
- Author
-
Dao MH, Phan LT, Cao TM, Luong QC, Pham HTT, Vu NHP, Khuu NV, Nguyen TV, Nguyen LT, Nguyen HT, Nguyen AH, Huynh LKT, Huynh TP, Nguyen QH, Truong HC, Nguyen HM, Trinh TX, Nguyen DT, Nguyen TB, Do HT, Pham QD, and Nguyen TV
- Subjects
- Adolescent, Adult, Aged, COVID-19 epidemiology, COVID-19 transmission, Contact Tracing, Female, Humans, Male, Middle Aged, Mutation, Phylogeny, Quarantine, Regression Analysis, Vietnam epidemiology, Whole Genome Sequencing, Young Adult, COVID-19 virology, Genetic Variation, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, Spike Glycoprotein, Coronavirus genetics
- Abstract
Genome-wide analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains is essential to better understand infectivity and virulence and to track coronavirus disease 2019 (COVID-19) cases and outbreaks. We performed whole-genome sequencing of 27 SARS-CoV-2 strains isolated between January 2020 and April 2020. A total of 54 mutations in different genomic regions was found. The D614G mutation, first detected in March 2020, was identified in 18 strains and was more likely associated with a lower cycle threshold (<25) in real-time reverse-transcription polymerase chain reaction diagnostic tests than the original D614 (prevalence ratio = 2.75; 95% confidence interval, 1.19-6.38). The integration of sequencing and epidemiological data suggests that SARS-CoV-2 transmission in both quarantine areas and in the community in Vietnam occur at the beginning of the epidemic although the country implemented strict quarantine quite early, with strict contact tracing, and testing. These findings provide insights into the nature of the epidemic, as well as shape strategies for COVID-19 prevention and control in Vietnam., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
290. Ilex kudingcha C.J. Tseng Mitigates Phenotypic Characteristics of Human Autism Spectrum Disorders in a Drosophila Melanogaster Rugose Mutant.
- Author
-
Pham HTN, Tran HN, Le XT, Do HT, Nguyen TT, Le Nguyen C, Yoshida H, Yamaguchi M, William FR, and Matsumoto K
- Subjects
- Animals, Autism Spectrum Disorder metabolism, Circadian Rhythm drug effects, Drosophila melanogaster genetics, Gene Expression drug effects, Hippocampus metabolism, Humans, Ilex chemistry, Locomotion drug effects, Memory, Short-Term drug effects, Methylphenidate therapeutic use, Phenotype, Plant Leaves chemistry, Presynaptic Terminals drug effects, Social Interaction drug effects, Vietnam, Autism Spectrum Disorder drug therapy, Nootropic Agents therapeutic use, Plant Extracts therapeutic use
- Abstract
Autism spectrum disorders (ASD) have heterogeneous etiologies involving dysfunction of central nervous systems, for which no effective pan-specific treatments are available. Ilex kudingcha (IK) C.J. Tseng is a nootropic botanical used in Asia for neuroprotection and improvement of cognition. This study establishes that a chemically characterized extract from IK (IKE) mitigates behavioral traits in the Drosophila melanogaster rugose mutant, whose traits resemble human ASD, and examines possible mechanisms. IKE treatment significantly ameliorated deficits in social interaction, short-term memory, and locomotor activity in Drosophila rugose, and significantly increased synaptic bouton number of size more than 2 μm
2 in the neuromuscular junctions (NMJs) of Drosophila rugose. To clarify mechanism(s) of IKE action, methylphenidate (MPH), a dopamine transporter inhibitor, was included as a reference drug in the behavioral assays: MPH significantly improved social interaction and short-term memory deficit in Drosophila rugose; administration of the dopamine D1 receptor antagonist SCH23390 and dopamine D2 receptor antagonist sulpiride reversed the ameliorative effects of both MPH and IKE on the social interaction deficits of Drosophila rugose. To extend analysis of IKE treatment to the vertebrate central nervous system, ASD-associated gene expression in mouse hippocampus was studied by RNA-seq: IKE treatment altered the expression of genes coding phosphoinositide 3-kinases/protein kinase B (PI3K-Akt), proteins in glutamatergic, dopaminergic, serotonergic, and GABAergic synapses, cAMP response element-binding protein (CREB), and RNA transporter proteins. These results provide a foundation for further analysis of IKE as a candidate for treatment of some forms of ASD.- Published
- 2021
- Full Text
- View/download PDF
291. Maternal and neonatal outcomes related to Zika virus in pregnant women in Southern Vietnam: An epidemiological and virological prospective analysis.
- Author
-
Grant R, Nguyen TTT, Dao MH, Pham HTT, Piorkowski G, Pham TDT, Cao TM, Huynh LTK, Nguyen QH, Vien LDK, Lemoine F, Zhukova A, Hoang DTN, Nguyen HT, Nguyen NT, Le LB, Ngo MNQ, Tran TC, Le NNT, Nguyen MN, Pham HT, Hoang TTD, Dang TV, Vu AT, Nguyen QNT, de Lamballerie X, Pham QD, Luong QC, and Fontanet A
- Abstract
Background: In 2016-2017, 68 women in Southern Vietnam had RT-PCR confirmed Zika virus (ZIKV) infection during pregnancy. We report here the outcomes of the pregnancies and the virological analyses related to this outbreak., Methods: We collected clinical and epidemiological information from the women who were enrolled in the study. Medical records related to the pregnancy in 2016-2017 were retrieved for those who were not able to be enrolled in the study. Children born to women with ZIKV infection during pregnancy were also enrolled. Serum samples were evaluated for presence of ZIKV antibodies. Phylogenetic analyses were performed on Zika virus genomes sequenced from the 2016-2017 serum samples., Findings: Of the 68 pregnancies, 58 were livebirths and 10 were medically terminated. Four of the medical records from cases of fetal demise were able to be retrieved, of which one was consistent with congenital ZIKV infection. Of the 58 women with a livebirth, 21 participated in the follow-up investigation. All but two women had serologic evidence of ZIKV infection. Of the 21 children included in the study (mean age: 30.3 months), 3 had microcephaly at birth. No other clinical abnormalities were reported and no differences in neurodevelopment were observed compared to a control group. Phylogenetic analysis revealed a clade within the ZIKV Asian lineage and branch at the root of samples from the 2013-2014 French Polynesian outbreak. The prM S139N mutation was not observed., Interpretation: We have been able to demonstrate a clade within the ZIKV Asian lineage implicated in adverse pregnancy outcomes in Southern Vietnam., Funding: INCEPTION project (PIA/ANR-16-CONV-0005) and a grant received from BNP Paribas Simplidon., Competing Interests: All authors declare no competing interests., (© 2021 The Author(s). Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
292. New SARS-CoV-2 variant of concern imported from the United Kingdom to Vietnam, December 2020.
- Author
-
Dao MH, Nguyen HT, Nguyen TV, Nguyen AH, Luong QC, Vu NHP, Pham HTT, Nguyen TNT, Thach DH, Nguyen LV, Bui LV, Nguyen HM, Huynh LKT, Nguyen LT, Cao TM, Pham QD, Nguyen TV, and Phan LT
- Subjects
- Adult, COVID-19 diagnosis, Communicable Diseases, Imported diagnosis, Female, Genome, Viral genetics, Humans, Male, Mutation, Phylogeny, SARS-CoV-2 classification, SARS-CoV-2 isolation & purification, Vietnam epidemiology, COVID-19 virology, Communicable Diseases, Imported virology, SARS-CoV-2 genetics
- Published
- 2021
- Full Text
- View/download PDF
293. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.
- Author
-
Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, and Klatzmann D
- Subjects
- Adult, Autoimmune Diseases immunology, Female, Humans, Immunologic Factors immunology, Interleukin-2 immunology, Male, Middle Aged, Prospective Studies, T-Lymphocytes, Regulatory immunology, Treatment Outcome, Autoimmune Diseases drug therapy, Immunologic Factors administration & dosage, Interleukin-2 administration & dosage, T-Lymphocytes, Regulatory drug effects
- Abstract
Objective: Regulatory T cells (Tregs) prevent autoimmunity and control inflammation. Consequently, any autoimmune or inflammatory disease reveals a Treg insufficiency. As low-dose interleukin-2 (ld-IL2) expands and activates Tregs, it has a broad therapeutic potential., Aim: We aimed to assess this potential and select diseases for further clinical development by cross-investigating the effects of ld-IL2 in a single clinical trial treating patients with 1 of 11 autoimmune diseases., Methods: We performed a prospective, open-label, phase I-IIa study in 46 patients with a mild to moderate form of either rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, psoriasis, Behcet's disease, granulomatosis with polyangiitis, Takayasu's disease, Crohn's disease, ulcerative colitis, autoimmune hepatitis and sclerosing cholangitis. They all received ld-IL2 (1 million IU/day) for 5 days, followed by fortnightly injections for 6 months. Patients were evaluated by deep immunomonitoring and clinical evaluation., Results: ld-IL2 was well tolerated whatever the disease and the concomitant treatments. Thorough supervised and unsupervised immunomonitoring demonstrated specific Treg expansion and activation in all patients, without effector T cell activation. Indication of potential clinical efficacy was observed., Conclusion: The dose of IL-2 and treatment scheme used selectively activate and expand Tregs and are safe across different diseases and concomitant treatments. This and preliminary indications of clinical efficacy should licence the launch of phase II efficacy trial of ld-IL2 in various autoimmune and inflammatory diseases., Trial Registration Number: NCT01988506., Competing Interests: Competing interests: MR, RL, PC, FB, BF, PC, JS, DS, CB and DK are inventors for patent applications related to the therapeutic use of ld-IL2, which belongs to their academic institutions and has been licensed to ILTOO Pharma. MR, VD, JM and DK hold shares in ILTOO Pharma. HPP, VD and JM are employees of ILTOO Pharma. No other potential conflicts of interest relevant to this article were reported., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
294. Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations.
- Author
-
Nguyen HH, Nguyen HTT, Vu NP, Le QT, Pham CM, Huyen TT, Manh H, Pham HLB, Nguyen TD, Le HTT, and Van Nong H
- Subjects
- Adult, Alleles, Asian People, Child, Preschool, Cohort Studies, DNA Mutational Analysis, Exons, Female, Gene Expression, Humans, Infant, Male, Promoter Regions, Genetic, Retina metabolism, Retina pathology, Retinal Neoplasms diagnosis, Retinal Neoplasms ethnology, Retinal Neoplasms pathology, Retinoblastoma diagnosis, Retinoblastoma ethnology, Retinoblastoma pathology, Genetic Predisposition to Disease, Germ-Line Mutation, Inheritance Patterns, Retinal Neoplasms genetics, Retinoblastoma genetics, Retinoblastoma Binding Proteins genetics, Ubiquitin-Protein Ligases genetics
- Abstract
Purpose: Retinoblastoma (Rb) is a rare and unique eye cancer that usually develops in the retinas of children less than 5 years old due to mutations in the RB1 gene. About 40% of affected individuals have the heritable form making genetics testing of the RB1 gene important for disease management. This study aims to identify germline mutations in RB1 in a cohort of patients with Rb from northern Vietnam., Methods: Genomic DNA was extracted from peripheral blood of 34 patients with Rb (nine unilateral and 25 bilateral cases) and their available parents. Twenty-seven exons, flanking sequences, and the promoter region of RB1 gene were screened for mutations with direct PCR sequencing. Multiplex ligation-dependent probe amplification (MLPA) was applied for patients with negative sequencing results. In the mutation-positive patients, their available parental DNA was analyzed to determine the parental origin of the mutation., Results: Germline mutations in RB1 were identified in 25 (73.53%) of 34 patients (four unilateral and 21 bilateral cases). Of these mutations, 19 were detected, including seven nonsense, six frameshift, four splice-site (one was identified in two siblings), and one missense, with Sanger sequencing. Three novel frameshift mutations were discovered in one unilateral and two bilateral patients. MLPA detected mutations in the RB1 gene in six bilateral cases, of whom five had a whole gene deletion (three familial cases) and one had a partial gene deletion (from exon 4 to exon 27) in one allele of the RB1 gene. Parental testing showed five mutations originated from the fathers and one was inherited from a mother who was mosaic for the mutation., Conclusions: This study provides a data set of germline mutations in the RB1 gene in Vietnamese patients with retinoblastoma. Screening of mutations in the RB1 gene can help to identify heritable Rb and contribute to clinical management and genetic counseling for affected families.
- Published
- 2018
295. Type I Dural Arteriovenous Fistula Mimicking Dural Venous Thrombosis-Related Intracranial Hypertension.
- Author
-
Pham H and Khanna S
- Subjects
- Cerebral Angiography, Humans, Venous Thrombosis, Central Nervous System Vascular Malformations, Intracranial Hypertension
- Published
- 2017
- Full Text
- View/download PDF
296. Organophosphate retinopathy.
- Author
-
Pham H, Lingao MD, Ganesh A, Capasso JE, Keep R, Sadagopan KA, and Levin AV
- Abstract
Organophosphates have rarely been reported to cause various ocular sequelae including retinal degeneration. Retinal manifestations have been rarely reported and poorly characterized. We describe a case of a 76-year-old man with vision loss beginning in his 20s due to acute on chronic exposure to dimethoate, an organophosphate. He presented with bilateral geographic macular atrophy and midperipheral pigmentary clumping which we characterized by dilated fundoscopic examination, optical coherence tomography, and fundus autofluorescence.
- Published
- 2016
- Full Text
- View/download PDF
297. Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.
- Author
-
Preisitsch M, Harmrolfs K, Pham HT, Heiden SE, Füssel A, Wiesner C, Pretsch A, Swiatecka-Hagenbruch M, Niedermeyer TH, Müller R, and Mundt S
- Abstract
Correction to: The Journal of Antibiotics (2015) 68, 165–177; doi:10.1038/ja.2014.118, published online 3 September 2014. The authors noted errors upon publication of this article in the ‘Results and Discussion’ section. The molecular formulas presented for compounds 1–5 in the "Isolation procedure and structure elucidation" section are incorrect. These formulas should read as follows: 1. C37H57NO7 2. C37H56ClNO7 3. C38H56Cl2N2O8 4. C37H55Cl2NO7 5. C37H54Cl3NO7
- Published
- 2015
- Full Text
- View/download PDF
298. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
- Author
-
Nguyen HT, Duc NB, Shrivastava R, Tran TH, Nguyen TA, Thang PH, McNicholl JM, Leelawiwat W, Chonwattana W, Sidibe K, Fujita M, Luu CM, Kakkar R, Bennett DE, Kaplan J, Cosimi L, and Wolfe MI
- Subjects
- Adolescent, Adult, Female, Genotype, HIV Infections drug therapy, HIV Infections epidemiology, HIV Infections virology, HIV Protease genetics, HIV Reverse Transcriptase genetics, HIV-1 enzymology, Humans, Male, Mutation, National Health Programs, Population Surveillance, Pregnancy, Prenatal Care, Program Evaluation, Treatment Outcome, Vietnam epidemiology, World Health Organization, Anti-Retroviral Agents therapeutic use, Counseling, Drug Resistance, Viral genetics, HIV Infections transmission, HIV-1 genetics, Molecular Diagnostic Techniques
- Abstract
Background: In countries where antiretroviral therapy has been available or is being rapidly expanded, the World Health Organization (WHO) recommends surveillance for transmitted HIV drug resistance (HIVDR) by threshold surveillance methods using specimens from antenatal clinics or voluntary counselling and testing (VCT) sites. The aim of this study was to implement the HIVDR threshold survey in VCT sites in Vietnam, where HIV prevalence is high. Estimating transmitted resistance in the infected population will enable the appropriateness of current antiretroviral drug regimens to be assessed and will inform plans for future HIVDR surveillance., Methods: Consecutive blood specimens were collected from 70 newly diagnosed HIV-positive clients 18-24 years of age at two sites in Hanoi, Vietnam. Informed consent and serum specimens were obtained from each eligible client, with serum frozen at -70 degrees C until shipping to Thailand for resistance testing using the TruGene system., Results: From February until August 2006, 559 clients were eligible to participate in this survey. Of the 535 clients (95.7%) who agreed to participate, 70 (13%) were HIV-positive and were included in the survey. Of the 70 specimens sent for genotyping, 52 consecutive samples were amplified, 49 of which could be genotyped. Only 1 of 49 genotyped specimens had mutations associated with drug resistance (L74V and Y181C) in the reverse transcriptase gene, indicating that the prevalence of transmitted HIVDR to all drugs and drug classes evaluated was <5%., Conclusion: The prevalence of transmitted HIVDR was low in Hanoi as determined using threshold surveillance methods. The Ministry of Health plans to repeat this survey methodology in one more province and to confirm these findings by expanded HIVDR surveillance.
- Published
- 2008
299. The lives of female sex workers in Vietnam: Findings from a qualitative study.
- Author
-
Ngo AD, McCurdy SA, Ross MW, Markham C, Ratliff EA, and Pham HT
- Subjects
- Activities of Daily Living, Adolescent, Adult, Anecdotes as Topic, Female, Focus Groups, Humans, Poverty, Sex Work psychology, Social Control, Informal, Social Perception, Surveys and Questionnaires, Unsafe Sex statistics & numerical data, Vietnam epidemiology, Women, Working psychology, Dominance-Subordination, Interpersonal Relations, Power, Psychological, Sex Work statistics & numerical data, Women's Health, Women, Working statistics & numerical data
- Abstract
To facilitate better understanding of the environment and power structures in which sex work in Vietnam takes place, this study examined the sex workers' social and economic lives, their working environment, social relationships and presentation of self in everyday social contacts and interactions. Thirty in-depth interviews and 14 focus groups were conducted with street-based and venue-based sex workers in the cities of Da Nang and Hanoi. Results show that sex workers live and work within a complex system involving multiple relationships. In any of these relations, women have limited power to protect their personal security and secure payment for services rendered. Economic hardship is a major problem facing street-level sex workers and contributes to unsafe sexual practices. Venue-based sex workers worry less about economic hardships as such, but frequently incur gambling debts. Women also reported incidents of abuse and experiences of social stigma. Although many women exhibited a strong desire to leave sex work, they found themselves trapped in the sex industry by the lack of alternative employment options. This study provides evidence that socio-psychological factors must be addressed along with risky behaviours to promote women's well-being and social integration.
- Published
- 2007
- Full Text
- View/download PDF
300. Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp.
- Author
-
Bui HT, Jansen R, Pham HT, and Mundt S
- Subjects
- Drug Screening Assays, Antitumor, Female, Humans, Microbial Sensitivity Tests, Molecular Structure, Staphylococcus aureus drug effects, Tumor Cells, Cultured, Vietnam, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents isolation & purification, Antineoplastic Agents pharmacology, Hydrocarbons, Chlorinated chemistry, Hydrocarbons, Chlorinated isolation & purification, Hydrocarbons, Chlorinated pharmacology, Nostoc chemistry, Polycyclic Compounds chemistry, Polycyclic Compounds isolation & purification, Polycyclic Compounds pharmacology
- Abstract
Five new paracyclophanes, carbamidocyclophanes A-E (1-5), characterized by carbamido side chains at a symmetric [7.7]paracyclophane ring, have been isolated from the biomass of the Vietnamese Nostoc sp. CAVN 10. Structure elucidation by spectroscopic methods showed that 1-5 vary in the substitution pattern of the chlorinated butyl side chains. The compounds exhibited cytotoxic activity against MCF-7 (breast cancer cell line) and Fl cells (human amniotic epithelial cell line) and moderate antibacterial activity against the Gram-positive bacterium Staphylococcus aureus.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.